I saw a 39 year old woman in clinic last week. She’d been short of breath for a year and half.

In that time she’d seen her primary care doctor three times and urgent care twice. Eventually an ED visit. She’d had chest X-rays, an EKGs, multiple labs. Her oxygen sats were 97-98% every single visit. She was told she was deconditioned. She was told it was stress. One note in her chart said “anxiety versus panic disorder, discussed breathing techniques.”

She came to me because she couldn’t walk from her car to her office without stopping. She’d started parking in the closest spot to the entrance. She’d stopped telling people about it because they kept telling her to exercise more.

Her chest X-ray was normal. Her spirometry was normal. Her resting oxygen sat was still 98 percent.

We ordered an in lab pulmonary function test that showed isolated reduced diffusion capacity. We then ordered an echocardiogram.

The echocardiogram showed a severely elevated pulmonary artery systolic pressure. A Right heart cath later confirmed pulmonary arterial hypertension — a progressive, life-threatening disease — that had been progressively worsening while she was told it was anxiety and handed breathing exercises.

In the United States, more than half of pulmonary arterial hypertension patients receive at least one misdiagnosis before the correct one. The average time from symptom onset to confirmed diagnosis is over two years. A diagnostic delay longer than that carries a measurable, statistically significant increase in mortality risk. (1, 2)

What shortness of breath means — and why it is not a diagnosis

Shortness of breath — medical term being “dyspnea” — is a symptom, not a diagnosis. This distinction matters. Chest pain isn’t a diagnosis. Shortness of breath isn’t either. It’s a signal that something is off in a system with a lot of moving parts: the lungs, the heart, the upper airways, the blood, the respiratory muscles.

When a patient comes to my pulmonary clinic with unexplained shortness of breath, the question I’m trying to answer isn’t “is this anxiety or not.” I’m trying to figure out the actual physiology, and has anyone looked at it comprehensively?

This requires a different kind of evaluation than most patients have had before coming into my clinic.

What a pulmonologist checks for shortness of breath

Before any test is ordered, there is a structured clinical history. Not only “how long has this been going on.” Precise questions that can point in precise directions.

Is the shortness of breath worse lying flat? That pattern, called orthopnea, often points toward the heart. Is it worse with activity or exertion or also at rest? Anxiety-related breathlessness is frequently present at rest and can improves with physical activity. Pulmonary and cardiac causes worsen with activity. Does it feel like an inability to breathe in, or an inability to breathe out? Is there a constant urge to sigh, to yawn, to reach for a breath that never quite feels complete?

That last pattern sometimes has clinical specificity. Anxiety-related dyspnea characteristically presents as breathlessness not tied to exertion, difficulty achieving a satisfying inhalation, and a compulsive need to sigh or yawn for temporary relief. (3) Recognizing it matters — but it only carries diagnostic weight after all structural causes have been excluded.

Pulmonary function testing (PFT)

A chest X-ray shows structure. Pulmonary function testing shows function. These are looking at the lungs from different angles, and a normal answer to the first does not answer the second.

Spirometry measures airflow — how much air moves in and out of the lungs, and how quickly. It identifies obstructive patterns that may suggest COPD or asthma- chest x-rays can be completely normal in these conditions. Research has documented that in community-based patients being actively treated with inhalers for breathing symptoms, fewer than half had ever had spirometry performed. (4) Some of these patients were treated for conditions they may not have ever had, while conditions they did have probably went undetected.

In-lab full pulmonary function testing extends beyond spirometry to include lung volumes and diffusion capacity measurements.

Lung volume testing is usually done by plethysmography in a “body box”. It helps diagnose conditions such as restrictive or interstitial lung disease. In patients with COPD or asthma, it can show air trapping or hyperinflation.

Diffusion capacity — measured as DLCO, or the diffusing capacity of the lungs for carbon monoxide — measures how efficiently oxygen crosses from the air sacs of the lungs into the bloodstream. A patient can have entirely normal spirometry and lung volumes, but a significantly reduced diffusion capacity. This can be seen in pulmonary hypertension.

Cardiac testing

Shortness of breath is not exclusively a lung problem. Heart failure — particularly diastolic dysfunction, where the heart muscle stiffens and cannot relax properly — causes exertional breathlessness that can mimic anxiety. Early pulmonary hypertension can do the same.

An echocardiogram is often the first cardiac test ordered to identify cardiac causes of unexplained shortness of breath. Especially if the lung evaluation was completely normal. Sometimes we order continuous EKG monitoring to look for arrhythmia. Sometimes we refer to cardiology to evaluate for cardiac stress testing or a cardiac catheterization.

The questions that raise suspicion for cardiac causes- Does it wake you from sleep? Is there ankle swelling? Did symptoms begin gradually over months? Do you feel or heart racing or have palpitations?

Chest CT scan

Not every patient with unexplained shortness of breath needs a chest CT. But some do. A CT of the chest identifies early interstitial changes, ground-glass opacities, and structural lung and airway abnormalities that plain chest x-rays can miss entirely. The indication is clinical — driven by the pattern of symptoms, pulmonary function test results, physical exam findings, and risk factors — it is not always reflexively ordered.

Exercise testing

Some patients have normal resting lung function, but abnormal exertional physiology. Their shortness of breath is only with exertion or activities.

A six-minute walk test can reveal low oxygen levels on exertion but completely normal oxygen levels at rest.

For patients with exertional symptoms and normal testing at rest (normal lung function testing, normal CT chest, normal cardiac testing), cardiopulmonary exercise testing is sometimes ordered to identify the precise physiologic limitation driving symptoms — is it a lung limitation, heart limitation, or something else. This is the same test done to measure VO2 max by fitness and longevity enthusiasts.

What conditions are misdiagnosed as anxiety when shortness of breath is the presenting symptom

Asthma (especially when atypical without cough or wheezing) can be misdiagnosed as anxiety. With normal lung function testing and chest imaging.

Early COPD in non-smokers. COPD is not exclusively caused by cigarette smoking. Occupational exposures, environmental pollution, recurrent early-life respiratory infections, and genetic conditions such as alpha-1 antitrypsin deficiency all produce airflow obstruction pattern with associated symptoms similar to smokers with COPD.

Early interstitial lung disease (ILD). Early ILD has normal findings on chest x-rays. The physical exam finding that most consistently points toward it — fine inspiratory crackles at the lung bases — can be subtle and easily missed in a brief clinical encounters in a primary clinic or urgent care.

Vocal cord dysfunction. Vocal cord dysfunction (VCD), also called inducible laryngeal obstruction (ILO), is the most direct clinical mimic of anxiety-related breathlessness. During inhalation the vocal cords adduct — close — when they should open. The result is sudden, severe breathlessness with throat tightness and a sensation of choking, without oxygen desaturation, without expiratory wheeze, and without response to bronchodilators. It presents like a panic attack, is triggered by stress and exercise, and has been reported to be found in up to 30 percent of patients referred for refractory asthma.(7) VCD is also commonly attributed to anxiety and panic disorder, particularly in women. The definitive treatment is speech therapy with breathing retraining.

Pulmonary hypertension. Pulmonary hypertension one of the missed diagnoses with the highest stakes. Exertional breathlessness, fatigue, and occasional lightheadedness maybe the only presenting symptoms — all nonspecific. The initial basic workup with chest x-rays, EKG, spirometry or basic labs is routinely normal. Younger women are disproportionately dismissed before this diagnosis is reached, their symptoms attributed to anxiety or poor fitness.(9) By the time diagnosis is confirmed, the average American patient has seen about three physicians and received at least one incorrect diagnosis. (1)

Anemia and thyroid disease. These are identified with basic laboratory testing. They are sometimes not drawn when the clinical encounter has moved quickly toward an anxiety explanation.

When anxiety is the correct diagnosis

Anxiety disorders can cause real physiologic changes. Hyperventilation, chest tightness, palpitations — the breathlessness that accompanies panic is not imagined. It responds well to breathing retraining, cognitive behavioral therapy, and, when indicated, medications. (10)

The problem is not diagnosing anxiety. The problem is diagnosing it first, before the more insidious causes have been ruled out.

Anxiety is a diagnosis of exclusion. It belongs at the end of a comprehensive evaluation, not at the beginning of a truncated one.

When I tell a patient their breathlessness is driven by anxiety, I want to be definitively sure about it. I want to say: we looked, we looked extremely carefully, nothing structural is driving this, and here is what that means for treatment.

That is a different conversation than “your chest X-ray is normal.”

A normal chest X-ray means the lungs appear structurally normal on a single two-dimensional image. It does not mean pulmonary function is normal. It does not mean pulmonary pressures are normal. It does not mean the upper airway is behaving normally under exertion. It means one basic test was negative.

Frequently asked questions about shortness of breath and misdiagnosis

Can anxiety cause shortness of breath?

Yes. Anxiety and panic disorders cause genuine physiologic changes that produce breathlessness — hyperventilation, chest tightness, air hunger. The symptoms are real. However, anxiety is a diagnosis of exclusion, meaning it should be confirmed only after pulmonary, cardiac, and other structural causes have been evaluated and excluded.

What tests should a doctor order for unexplained shortness of breath?

A complete evaluation for unexplained shortness of breath includes a detailed clinical history and physical exam, comprehensive pulmonary function testing, lab work including a complete blood count and thyroid function, and an echocardiogram when cardiac causes are suspected. Often a chest CT scan is done. Sometimes further cardiac testing for rhythm abnormalities or coronary artery disease is done. In a limited number of cases, cardiopulmonary exercise testing is done when all of the initial testing is completely normal.

Why does shortness of breath get misdiagnosed as anxiety?

Anxiety is common, anxiety causes real breathlessness, and the standard initial workup — chest X-ray, EKG and pulse oximetry — is frequently normal across multiple causes of dyspnea. Emergency departments and urgent care centers do not have pulmonary function testing. Visit times are short. A normal appearing patient with a normal oxygen saturation is reassuring, and anxiety becomes the default explanation when nothing obvious has been found. Also, they are focused on ruling out emergent or urgent conditions that maybe immediately life threatening.

What is a diffusion capacity or DLCO testing?

DLCO stands for diffusing capacity of the lungs for carbon monoxide. It measures how efficiently oxygen crosses from the air sacs of the lungs into the bloodstream. It is a standard part of complete pulmonary function testing and can detect early interstitial lung disease, pulmonary vascular disease, and emphysema even when spirometry and chest X-ray results are normal. The test takes approximately fifteen minutes and is noninvasive.

What is vocal cord dysfunction, and how does it mimic anxiety?

Vocal cord dysfunction, also called inducible laryngeal obstruction, is a condition in which the vocal cords close during inhalation rather than opening. This produces sudden, severe breathlessness with throat tightness that closely resembles a panic attack. Oxygen saturation remains normal during episodes. It does not respond to inhaler therapy. It is treated with speech therapy and breathing retraining. Studies estimate that nearly 80 percent of VCD cases are initially misdiagnosed, most commonly as asthma or anxiety.

What is pulmonary hypertension, and why is it missed?

Pulmonary hypertension is a condition of elevated blood pressure in the arteries supplying the lungs. Early symptoms — exertional breathlessness, fatigue, lightheadedness — are nonspecific and commonly attributed to anxiety or deconditioning, particularly in younger women. The diagnosis requires an echocardiogram and, for confirmation, a right heart catheterization — neither of which is part of a standard clinic or urgent care evaluation. In the US, more than half of pulmonary arterial hypertension patients receive at least one misdiagnosis before the correct one.

What should I ask my doctor if I think my shortness of breath has been misdiagnosed?

Ask specifically for a referral to pulmonology and request complete pulmonary function testing with lung volume and diffusion capacity testing. You can also ask whether an echocardiogram has been considered to evaluate for cardiac causes. You are not being difficult. You are being specific, which is one of the most important things you can do to advocate for yourself.

What to do if you have been told it is anxiety?

If the evaluation you received was a chest X-ray, a pulse oximeter reading, an EKG and basic labs — you have not had a comprehensive evaluation. Asking for one is not a second opinion. It is a first real one.

Leave a comment

Subscribe now

The information in this article is provided for educational purposes only. It reflects the clinical experience and perspective of a board-certified pulmonologist and critical care physician and is intended to help readers understand how shortness of breath is evaluated — not to diagnose or treat any individual condition.

Nothing here should be taken as personal medical advice or used as a substitute for evaluation, diagnosis, or treatment by a qualified healthcare provider who knows your history.

Shortness of breath has many causes, some of which require urgent attention. If you are experiencing shortness of breath that is sudden, severe, rapidly worsening, or accompanied by chest pain, palpitations, fainting, or bluish discoloration of the lips or fingernails, call 911 or go to your nearest emergency department immediately.

References

1. Small M, Perchenet L, Bennett A, Linder J. The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey. Pulmonary Circulation. 2024. In the United States, 51.3% of PAH patients received a misdiagnosis before correct diagnosis, seeing a mean of 2.9 physicians first.

2. Weatherald J, et al. The “great wait” for diagnosis in pulmonary arterial hypertension. Respirology. 2020. Diagnostic delay greater than two years was associated with an 11% increased risk of death, and average delay has not improved meaningfully since the 1980s NIH registry data.

3. Pratter MR, et al. Anxiety dyspnea: characteristic clinical presentation. PMID 24791552. Patients with anxiety-related dyspnea characteristically report dyspnea unrelated to exertion, difficulty achieving satisfying inhalation, and compulsive sighing or yawning.

4. Aaron SD, et al. Diagnostic practices for patients with shortness of breath and presumed obstructive airway disorders. PMC7527250. Fewer than half of community-based patients receiving inhaler therapy for breathing symptoms had ever had pulmonary function testing performed.

5. National Heart, Lung, and Blood Institute. Pulmonary Function Lab: Tests. DLCO measures transfer of gas from alveoli to pulmonary capillaries and can be reduced in ILD, pulmonary vascular disease, and emphysema with otherwise normal spirometry.

6. American Lung Association. COPD: Causes and Risk Factors. Non-smoking causes of COPD include occupational and environmental exposures, recurrent childhood respiratory infections, and alpha-1 antitrypsin deficiency.

7. Haque RA, et al. Vocal cord dysfunction: Rapid Evidence Review. American Family Physician. 2021. VCD is found in up to 30% of patients referred for difficult-to-control asthma and is frequently misdiagnosed as asthma or anxiety.

8. UT Southwestern Medical Center. Vocal cord dysfunction: breathing problems during exercise. Nearly 80% of VCD cases are initially misdiagnosed, most commonly as asthma.

9. American Lung Association. Pulmonary Arterial Hypertension: Symptoms and Diagnosis. Younger patients and patients with a history of common respiratory disorders are disproportionately likely to receive delayed diagnosis.

10. American Thoracic Society. Dyspnea mechanisms, assessment, and management: a consensus statement. Anxiety-related dyspnea responds to breathing retraining and cognitive behavioral approaches once structural causes have been excluded.

This is the context for everything that follows. Not a policy failure in the abstract. A real person with severe lung disease, choosing between her inhaler and her grocery bill. Without daily Trelegy, her shortness of breath worsens, her cough worsens, her lungs work harder.

I’ve seen frequently since January. Patient who have already done the math before they walk through my door. Who have already decided, quietly, that breathing may have to wait.

Let’s talk about why Susan’s inhaler costs $380.

The thing that almost nobody knows

In 2008, the United States EPA banned chlorofluorocarbon propellants from metered-dose inhalers. CFCs damage the ozone layer. The ban was the right call for the environment.

But what happened next was not a coincidence.

Every CFC-based inhaler on the market — including generic albuterol, which had been available for decades and cost almost nothing had to be reformulated. New propellant. New device. New manufacturing process. And under U.S. patent law, a new formulation gets a new patent.

Generic albuterol disappeared overnight.

What replaced it were HFA-propellant versions, all under fresh new patent, all priced like new drugs. Proventil HFA. ProAir HFA. Ventolin HFA. The same molecule that had been cheap for thirty years, now in a new device, now patented, now much more expensive. Prices went from roughly $10 to $40–80 for a rescue inhaler, overnight.

The manufacturers didn’t invent a better drug. They reformulated an existing one under regulatory pressure and then patented the packaging. The patent system allowed it. No law was broken.

For maintenance inhalers — the ones patients with COPD and asthma take every day, the ones that actually keep people out of the emergency room — the same math played out over years. New combinations, new patents, new exclusivity periods. A drug that’s been on the market for two decades can get another decade of exclusivity because someone combined it with something else in a single device and filed a new patent on the result.

Then add the fact that, until very recently, Medicare was legally barred from negotiating drug prices directly. When Congress created Medicare Part D in 2003, it included something called the noninterference clause — a provision explicitly prohibiting the government from stepping in between drug manufacturers and the plan sponsors who cover your medications. The VA negotiates. The Department of Defense negotiates. Medicare could not. The Inflation Reduction Act of 2022 created a limited exception — but the first negotiated prices took effect this year, for ten drugs, none of them inhalers. The inhaler negotiations come in 2027. For the decades in between, drug companies set a list price, and that was effectively the price Medicare paid.

What actually changed — and for whom

Two things happened in the last few years that matter, and I want to be honest about both of them.

The $35 cap is real. Three major inhaler manufacturers — GSK, AstraZeneca, Boehringer Ingelheim — committed to capping out-of-pocket costs at $35 a month. For commercially insured patients and uninsured patients, this applies.

The $35 cap does not apply to Medicare. Or Medicaid. Or TRICARE. This is due to a federal law designed to prevent pharmaceutical kickbacks to physicians, written decades before manufacturer savings programs existed, now effectively bars drug companies from offering those savings to any patient covered by a federal program. The law was not written to harm elderly COPD patients. But that is what is happening.

The Inflation Reduction Act introduced a $2,000 annual out-of-pocket cap for Medicare Part D, starting 2025. This is the most meaningful thing Congress has done for Medicare drug costs in years. Before 2025, there was no cap at all. Before 2025, a patient on multiple expensive medications could spend $8,000 in a year and Medicare had no ceiling on it.

The cap is real. It is not $35. On Trelegy at standard coinsurance, you’re paying out of pocket for most of the year before it kicks in. But once you hit $2000 ($2100 in 2026) your drug is free through December 31.

Trelegy and Breo Ellipta are now subject to Medicare price negotiation under the Inflation Reduction Act. New negotiated prices take effect January 2027. I don’t know what the final cost will be. I’ve been telling patients to watch for it, which is an unsatisfying thing to say to someone who can’t afford their refill now.

Generic inhalers in 2026: the situation is complicated

Generic albuterol — rescue inhalers — is back. Around $20–30 out of pocket at GoodRx. If you’re paying significantly more than that for albuterol, something is wrong with how your prescription is configured and I recommend to check with your pharmacist. One thing to know- not every Medicare Part D plan actually covers generic albuterol — only about 69% do, despite it being a generic. Brand-name Proventil, counterintuitively, is covered by 96% of plans. It’s worth checking your specific plan’s formulary.

For maintenance inhalers, it’s more complicated.

Generic budesonide/formoterol — sold as Breyna — became available in the US in 2024. Same active ingredients as Symbicort. About $97 on GoodRx versus $334–396 for the brand.

Generic fluticasone/salmeterol, the Advair equivalent, also exists. Wixela runs $55-110.

Generic tiotropium in the HandiHaler device — a Spiriva equivalent — can be had for $80 on GoodRx. This is the most underused substitution I see clinically. Patients on brand Spiriva at $683 retail who could be on generic tiotropium at a fraction of the cost, with identical efficacy. Often the switch requires nothing more than a prescription change.

There is no generic Trelegy. No generic Breztri. No generic Anoro. No generic Spiriva Respimat — the Respimat device itself is proprietary. If your medication is in one of these categories, the options for affordability are different: manufacturer assistance programs, formulary navigation, or in some cases a clinical switch your doctor can make without restarting the prior authorization process from scratch.

One note on GoodRx: it’s legitimate and often genuinely useful. The catch is structural — paying cash through GoodRx means that cost doesn’t count toward your Medicare Part D deductible or your $2,100 out of pocket (OOP) cap. For cheap generics, GoodRx often wins even accounting for this. For expensive maintenance inhalers when you’re tracking toward the OOP cap anyway, you’re usually better off staying inside your Part D plan. Your pharmacist can run both numbers in about two minutes. Ask them.

What I tell patients

When someone sits across from me and says they’re rationing their inhaler, I don’t have a clean answer. I have a set of questions: What insurance do you have? What drug exactly? What did you pay last time? Have you ever applied for Extra Help? Does your income qualify for a manufacturer program? Have you checked GoodRx or Costplus for out of pocket cost?

Most of the time there’s something we can find to make it affordable. A generic that works as well. A program they’ve never heard of. A nebulized alternative covered under a completely different part of Medicare (Part B). A formulary tier appeal worth filing.

My patient, Susan, who was dosing every other day — we found a way to get her Trelegy more affordable. It took three phone calls and filling out two forms to get her into a manufacturer assistance program. It should not require a physician making three phone calls and two forms to solve a problem created by patent law and more than a decade old EPA environmental regulation.

That’s where we are in 2026, in the United States. We cover some real options in Part 2- options most patients and many doctors aren’t even aware of.

Subscribe now

Share

Leave a comment

Before we start: If you haven’t mapped your triggers yet, start with Part 3. Knowing which resources you need depends on understanding your own specific patterns.

Here are links to Part 1 and Part 2 of the series.

Like I mentioned in Part 1, our best treatment package for quitting smoking gets only ~25% of people to quit. In perfect study situations where all medications are covered and patients receive great counseling support and follow-up, the quit rates are reported to be upwards of ~35-40%.

I want to maximize your own chances to finally quit smoking by-

1) Finding your Why to quit (Part 2)

2) Mapping your triggers (Part 3).

3) Starting combination therapy with medications (varenicline or buproprion AND NRT) + behavioral/counseling support. This is best planned with your doctor or healthcare provider for ongoing support.

Subscribe now

Share

Tier 1: Smoking Cessation Treatments With the Strongest Evidence

1. Varenicline (Chantix) - The Current Champion

What it is: A prescription medication that blocks nicotine receptors in your brain and reduces both cravings and the rewarding feeling you get from smoking.

The evidence: Varenicline is the most effective pharmacotherapy we have for smoking cessation¹. It roughly doubles to triples your chances of quitting compared to placebo. Absolute success rates vary between studies—typically ranging from 20-35% at one year when combined with counseling—but that’s still significantly better than the 10-15% you’d get with placebo and counseling, or the 3-6% with no help at all².

Common side effects: Nausea, weird or vivid dreams, sometimes mood changes. There was a black box warning about psychiatric side effects for years, but it was removed by the FDA after further research showed the risk was lower than initially thought³. Still, if you have a history of depression or anxiety, talk to your doctor before starting this medication.

Cost: It used to be expensive without insurance ($400-500 for 12 weeks). More recently since going generic, you can get it through discount online programs for $30-$50 (eg. GoodRx).

2. Bupropion (Zyban/Wellbutrin) - The Solid Second Choice

What it is: An antidepressant that also helps with quitting smoking by affecting dopamine and norepinephrine in your brain.

The evidence: Bupropion increases your likelihood of quitting by roughly 60-80% compared to placebo⁴. It’s not quite as effective as varenicline in head-to-head trials, but it’s a pretty good option, especially if you also deal with depression.

Common side effects: Caution if you have seizure disorders or eating disorders. Can cause insomnia, dry mouth, sometimes increased anxiety. Some people get a mood boost from it (it is an antidepressant), which can help with the quitting process.

Cost: Generally cheaper than varenicline and generic versions available.

3. Nicotine Replacement Therapy (NRT) - The Accessible Option

What it is: Patches, gum, lozenges, inhalers, nasal spray - all deliver nicotine without the tar and toxins from cigarettes.

The evidence: NRT increases your likelihood of quitting by about 50-70% compared to placebo (odds ratio 1.70)⁶. In absolute terms, this means success rates of around 15-20% at one year with NRT versus 3-6% without any support. Combination NRT (patch + gum or lozenge) works better than single products⁷.

Common side effects: You’re still getting nicotine (though without the thousands of other toxic chemicals in cigarette smoke). Some people get skin irritation from patches, jaw soreness from gum. Takes longer to work than the medications.

Cost: NRT can run about $30-80 per month. Many insurances cover NRT. Quit lines and state programs will sometimes provide it for free. Discount programs such as GoodRx can also lower the costs quite a bit.

4. Quit lines (1-800-QUIT-NOW) - The Free Resource

What it is: Free telephone counseling provided by trained specialists. You call, they help you make a quit plan, provide coaching, sometimes provide free NRT (depending on which state you’re in) and information on other local resources.

The evidence: Telephone quit lines increase your chances of quitting by about 25-60% compared to no support⁸. Studies show proactive calls (where they call you back) work better than single reactive calls⁹. The data on this is solid - quit lines work, and they roughly double the effect when combined with medication.

While absolute success rates vary between studies, the intervention consistently shows benefit. One major trial found 9.1% sustained abstinence at 12 months with quit line counseling - not amazing on its own, but a meaningful improvement over going it alone¹⁰.

The downsides: You have to actually call and engage. Some people feel awkward talking on the phone. The counselors aren’t doctors, so they can’t prescribe medications like chantix (but they can connect you to resources that provide them). Quality can also vary quite a bit by state.

Cost: FREE. Tax dollars already paid for this.

5. Text-Based or App-based Support Programs

What it is: SMS text message support programs that send you reminders, tips, and encouragement. Some allow you to text back for support when cravings hit. There are APP based programs like QuitSTART, the evidence for efficacy is still emerging but overall positive.

The evidence: Studies show modest improvement in quit rates (about 1.3-1.5x better than no support)²⁴. Works better for younger smokers and when messages are personalized. On-demand features are more helpful than scheduled messages alone.

Popular programs:

• SmokefreeTXT (free, from National Cancer Institute)

  • Text QUIT to 47848

• Text2Quit (paid, around $30)

• QuitSTART app includes texting, visual tracking, gamification and location based support.

If you hate talking on the phone (and many people do), this gives you structured support without the awkwardness of phone counseling. Messages come at strategic times - morning, after meals, whenever your triggers typically hit. You can also text for support when a craving strikes.

The downsides: Automated messages can feel impersonal. Easy to ignore or turn off. And the generic advice doesn’t always match your specific triggers. Some people find frequent texts annoying.

Cost: FREE for SmokefreeTXT

6. Behavioral Counseling

What it is: Working with a therapist or cessation counselor who specializes in smoking cessation, using cognitive-behavioral techniques.

The evidence: Behavioral counseling improves quit rates when combined with medication¹². The effect is modest but real - adding behavioral support to medication increases success by about 10-25% compared to medication alone.

This is most helpful if your triggers are primarily emotional or if you have co-occurring mental health issues. If you’re just habitually smoking after meals, you may not benefit as much from weekly therapy.

The downsides: Time-consuming, can be expensive if insurance doesn’t cover it, requires finding a qualified counselor who you have good rapport with.

Cost: $$$ - Often $100-200/session without insurance.

Important Note on Combination Therapy:

The success rates I’m quoting assume you’re combining medications with behavioral support (counseling, quit lines, text programs, etc.). Medication alone has lower rates. Counseling alone has lower rates. The combination of pharmacotherapy plus behavioral intervention is what gets you the best shot at quitting.

Tier 2: Smoking Cessation Options With Limited or Mixed Evidence

8. In-Person Support Groups

What it is: Group counseling through hospitals, community centers, or Nicotine Anonymous (12-step model similar to AA). Usually meet weekly.

The evidence: Group counseling modestly improves quit rates, with benefit similar to individual counseling²⁵. More intensive groups (more sessions) work better. Like everything else, works better combined with medications.

If you’re someone who benefits from peer support and likes the accountability of showing up somewhere, this can help. Hearing others’ struggles and strategies can be validating. The 12-step model (Nicotine Anonymous) works great for some people and feels cult-like to others.

The downsides: Quality varies wildly by group. Some are very 12-step focused (not for everyone). Schedule conflicts are common. Hearing about others’ relapses can be triggering or demotivating. May not address medication options adequately.

Cost: Usually free or sliding scale. Nicotine Anonymous is always free.

9. Online Communities -

What it is: r/stopsmoking on Reddit, Facebook groups, various forums where people trying to quit can support each other any time of day.

The evidence: Limited research, mostly observational data. Hard to study rigorously. Probably helps some people, but probably not most.

Real talk: These can be incredibly supportive or incredibly toxic, sometimes both in the same day. The anonymity helps people be honest about struggles, but also means you get unfiltered bad advice mixed with good advice. No professional moderation means quality control is nonexistent. I’ve seen people get amazing support and terrible advice within the same thread.

The downsides: Echo chambers. Bad advice gets upvoted if it sounds good. Unverified anecdotes presented as facts. Can reinforce rationalizations instead of challenging them. Some people find others’ relapse stories demotivating. Easy to spend hours reading instead of actually implementing strategies.

Cost: FREE

10. E-Cigarettes/Vaping (The Controversial Option)

What it is: Electronic devices that deliver nicotine through vapor instead of smoke.

The evidence: This is where it gets messy and where the evidence is rapidly evolving. Recent data suggests e-cigarettes may be more effective than nicotine replacement therapy. A major 2019 trial found 18% quit rate with e-cigarettes vs. 10% with NRT at one year¹⁴. The 2024 Cochrane systematic review concluded that nicotine e-cigarettes can help people quit smoking and appear more effective than NRT¹⁵.

However, the U.S. Preventive Services Task Force currently considers the evidence insufficient to make a formal recommendation for e-cigarettes as a cessation tool¹⁶. Few medical organizations are beginning to reconsider their cautious stance as more data accumulates, but e-cigarettes are not FDA-approved for smoking cessation in the US. Most medical societies/organizations discourage e-cigarette use to help quit smoking.

Real talk: Here’s my take as a pulmonologist: e-cigarettes are less harmful than combustible cigarettes, but they’re not harmless. If you’re going to vape, it should be very strictly as a bridge to quitting nicotine entirely, not a permanent replacement. And only after trying and failing with the evidence based therapies covered earlier in this article.

The major concerns:

• We don’t have long-term safety data (20+ years)

• Youth uptake is a massive public health problem

• Many people end up dual-using (vaping AND smoking)

• Not FDA-approved for smoking cessation

• Variable quality and nicotine content between products

Cost: $$ - Varies wildly depending on device and liquid

Tier 3: Smoking Cessation Methods That Research Shows Probably Don't Work

11. Hypnosis

What it is: A practitioner puts you in a hypnotic state and gives suggestions about quitting smoking.

The evidence: Weak to nonexistent. The gold-standard 2019 Cochrane review found insufficient evidence that hypnotherapy is more effective than other interventions or no treatment¹⁷. A 2024 systematic review found some positive results (66.7% of studies reported positive impact), but methodological issues in those studies (small sample sizes, lack of biochemical validation, poor randomization) make it hard to draw firm conclusions¹⁸. The Cochrane review remains the most rigorous assessment.

If hypnosis makes you feel relaxed and confident, fine. But you’re probably experiencing a placebo effect, and you’re definitely spending money that could go toward interventions with actual evidence behind them.

The downsides: Expensive, time-consuming, no better than cheaper alternatives.

Cost: $$$ - Often $200-500 per session, sometimes packages of multiple sessions

12. Acupuncture

What it is: Traditional Chinese medicine practice involving inserting thin needles into specific points on your body.

The evidence: A 2019 systematic review found that acupuncture may be superior to no intervention but is no better than sham acupuncture¹⁹. Another Cochrane review concluded there’s no consistent evidence that acupuncture has a sustained benefit on smoking cessation for 6+ months²⁰.

People report feeling more relaxed after acupuncture, which is nice. But relaxation doesn’t translate to higher quit rates. It’s essentially an expensive relaxation technique. The fact that it performs the same as sham acupuncture (where needles are placed randomly) tells you everything you need to know about mechanism.

The downsides: Can be expensive, requires multiple sessions, takes time.

Cost: $$ - Usually $50-100 per session, often need 6-12 sessions

13. “Laser Therapy” / “Cold Laser”

What it is: Low-level laser supposedly stimulates acupuncture points to reduce cravings.

The evidence: Same as acupuncture - which is to say, not compelling²¹.

Real talk: This is acupuncture with a laser instead of needles. Still doesn’t work better than placebo. Often marketed with impressive-sounding pseudoscience.

The downsides: Expensive, no evidence of efficacy.

Cost: $$$ - Often marketed as expensive packages ($300-500+)

Worth it? Absolutely not.

14. Herbal Supplements / “Natural” Remedies

What it is: Various plant-based products marketed for smoking cessation (St. John’s Wort, lobelia, various proprietary blends).

The evidence: Virtually none for most products. Not regulated by FDA. Quality and content vary wildly between brands.

“Natural” doesn’t mean safe or effective. Tobacco is natural too. If an herb actually worked for smoking cessation, pharmaceutical companies would have isolated the active compound and turned it into a medication. The fact that they haven’t tells you something.

The downsides: Unregulated, potential drug interactions, expensive, no evidence.

Cost: $$ - Varies

Worth it? No.

Tier 4: Quitting Cold Turkey — Why Unassisted Quitting Fails 95% of the Time

15. Cold Turkey (Unassisted Quitting)

What it is: Just stopping. No medication, no counseling, sheer willpower.

The evidence: Success rates are 3-6% at one year²². Most people try this first. Most people fail.

The downsides: Highest failure rate of any method. Often leads to multiple failed attempts and demoralization, which can make future attempts harder.

Cost: Free

How to Spot Smoking Cessation Scams: Red Flags to Watch For

Before you spend money on any smoking cessation program, watch for some warning signs:

Be wary of any program that:

• Claims >50% quit rates (if it sounds too good to be true, it is)

• Costs hundreds or thousands of dollars with no published evidence

• Promises “easy” or “painless” quitting (it’s not, and anyone claiming otherwise is lying)

• Uses only testimonials instead of published research

• Requires long-term contracts or subscriptions upfront

• Combines multiple unproven methods (hypnosis + acupuncture + herbs)

• Makes you feel bad for previous failed attempts

• Claims to work for “everyone”

• Won’t provide refunds or has predatory cancellation policies

Legitimate programs will:

• Be transparent about actual success rates (around 20-35% at best, usually lower)

• Provide evidence from published, peer-reviewed studies

• Offer free trials or reasonable money-back guarantees

• Be recommended by medical organizations (ALA, ACS, ATS)

• Acknowledge that quitting is hard and typically takes multiple attempts

• Encourage combination with FDA-approved medications

• Have qualified medical professionals involved

What Are Realistic Smoking Cessation Success Rates? The Honest Numbers

Even with the best evidence-based interventions combined - medication plus behavioral counseling - success rates top out around 25-30% at one year. That’s with everything working optimally.

This isn’t because you’re weak or you’re not trying hard enough. It’s because nicotine is incredibly addictive, and we’re fighting against decades of behavioral conditioning plus powerful brain chemistry.

Also remember many people need up to 8 to 10 attempts before finally quitting. So don’t feel demoralized if you relapse after quitting. Use it as an opportunity to troubleshoot what didn’t work during your last attempt and how your plan will change for the next quit attempt.

And re-review your why and your triggers.

And its never too late to quit smoking and you get a multitude of health benefits- breathing better, less risk of heart disease, strokes, lower risks of cancer (not only lung cancer but throat, gastric, pancreatic, etc.)

Next up in Part 5: How to use AI as your personal smoking cessation coach? - (Update 1/31/26)- I initially planned a Part 5 article on how to create an AI personal smoking cessation coach with chatgpt. Unfortunately, I ended up with mixed results of variable quality. Luckily there are already a few APP based options, and some that incorporate AI already out there!

• QuitBot- free AI powered coaching to quit smoking. Created by Fred Hutch Cancer Center

• Smoke Free APP

• Kwit

Share

Subscribe now

Leave a comment

Disclaimer: This article provides education about interventions/strategies for smoking cessation. It is not a substitute for medical advice. Consult your healthcare provider about medications and developing a comprehensive quit plan tailored to your situation. The combination of behavioral strategies, medication, and professional support provides the best chance of successfully quitting smoking.

References:

1. American Thoracic Society. Medications for Smoking Cessation: Guidelines. AAFP. 2021.

2. Efficacy of varenicline versus bupropion for smoking cessation. Meta-analysis of RCTs. 2023.

3. FDA Drug Safety Communication: FDA revises description of mental health side effects of Chantix (varenicline).

4. Hughes JR, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014.

5. Comparative effectiveness study of varenicline, bupropion and NRT. Tob Induc Dis. 2017.

6. Silagy C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004.

7. Mills EJ, et al. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation. Ann Med. 2012.

8. Stead LF, et al. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019.

9. Lichtenstein E, et al. Smoking cessation quitlines: an underrecognized intervention success story. Am Psychol. 2010.

10. Zhu SH, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002.

11. Fiore MC, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services.

12. Fiore MC, et al. The effectiveness of smoking cessation therapies combined with pharmacotherapy. 2008.

13. Whittaker R, et al. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016.

14. Hajek P, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019.

15. Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024.

16. US Preventive Services Task Force. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons. JAMA. 2021.

17. Barnes J, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2019.

18. Systematic Review on Hypnotherapy and Smoking Cessation. 2024.

19. Hong L, et al. Acupuncture for smoking cessation: A systematic review and meta-analysis of 24 randomized controlled trials. Tob Induc Dis. 2019.

20. White AR, et al. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2014.

21. Tahiri M, et al. Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med. 2012.

22. Babb S, et al. Quitting smoking among adults — United States, 2000–2015. MMWR. 2017.

23. American Thoracic Society recommendations on extended pharmacotherapy for smoking cessation. 2020.

24. Free C, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop). Lancet. 2011.

25. Stead LF, et al. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017.

Links to part 1 and part 2 of the series.

I saw a couple in clinic last week. I’ve been trying to get them both to quit smoking for the past 2 years. We tried chantix, nicotine patches and counseling and they actually did quit for 6 months, but then relapsed.

I asked them if they’ve thought about their triggers.

“We know our triggers,” the wife told me. “Stress and coffee.”

“Okay,” I said. “What kind of stress? When during the day? What are you doing when the stress hits?”

Pause. “Just you know...life is stressful?”

And here’s one of the key things we often gloss over during busy clinic visits. We hand people generic checklists of triggers they need to avoid like “stress” and “social situations”. What they actually need is a specific map of their own trigger patterns."Stress" isn't a useful trigger. Stress doing what? Stress from whom? At what time? That generic list is about as helpful as someone telling you "avoid traffic" when you're trying to drive to work during rush hour.

Most people have been smoking on autopilot for so long that they don’t actually know their triggers anymore.

Why Your Triggers Aren’t What You Think They Are

Here’s what usually happens: someone decides to quit, googles “smoking triggers,” finds similar lists on every website (stress, alcohol, coffee, social situations, after meals), and thinks “okay, I’ll avoid those.”

Problems with this approach:

Your “stress” is not the same as someone else’s stress. Maybe your real trigger is specifically anger at your boss during team meetings, not general stress. Maybe it’s Sunday evening anxiety about the work week, not stress while you’re actually working. Maybe it’s feeling overwhelmed by a family problem, not the stress of your own job.

Your “after meal smoke” might be breakfast but never dinner. Or only lunch at work but not lunch at home. Or specifically when grabbing a drink with specific friends. Or specifically being around your brother who still smokes, but no one else.

See the problem? Generic lists become useless because your brain has created specific associations over many years. This is why mapping personal triggers is essential.

What Are the Five Types of Smoking Triggers? A Framework for Mapping Them

Before we talk about the method, let’s be clear about what we’re looking for. You’re not making a list of “things that make me want to smoke.” You’re mapping five specific pattern types:

Time patterns. Not just “morning” but 7:15am when you’re making coffee, before anyone else is awake. Not just “after work” but specifically the 15-minute window between parking your car and walking into your house. Our brains are incredibly time-sensitive. You might have a cigarette trigger at 3pm every day that has nothing to do with what you’re doing—it’s just when your body expects nicotine.

Emotional triggers—and I mean specific emotions. Not “stress” but “angry at my annoying aunt after she criticizes my parenting.” Not “anxiety” but “dread about opening my email inbox.” Not “bored” but “restless at 10pm after the kids are in bed and I’m too tired to do anything productive but not tired enough to sleep.” Your brain doesn’t respond to generic emotions. It responds to very specific feeling states.

Social triggers. Which people. Which dynamics. Are you triggered by being around smokers? Or by being around your family even if they don’t smoke? By feeling left out when coworkers take smoke breaks? By specific conversations with specific people? By being alone when you’re usually with others?

Environmental triggers. Not just “in my car” but in your car specifically in the parking lot at work before walking into the building. Not just “at home” but standing on your back porch at dusk. Not just “bars” but that one specific bar where you always used to smoke. Our brains create location-based associations with precision.

Physical vs. behavioral. This is critical: actual nicotine withdrawal feels different than a behavioral habit. Nicotine cravings can hit anywhere at any time, especially in the first few weeks of quitting. Behavioral triggers are situational—they’re tied to specific contexts. If you only crave cigarettes after meals, that’s behavioral. If you’re getting hit with cravings at random times throughout the day, that’s physical withdrawal. You will need different strategies for each.

Why Real-Time Tracking Works Better Than End-of-Day Reflection

Self-monitoring is one of the most well-established components of behavioral therapy for smoking cessation. The key is tracking in real-time, not trying to remember at the end of the day. Here’s one effective method that works for a lot of my patients: use your phone’s voice recorder.

Not write it down. Not fill out a worksheet. Not think back at the end of the day and try to remember. Record it in real-time when a craving hits.

Why voice recording works well for many people:

Because it’s fast. When you’re triggered and your brain is screaming for nicotine, you’re not going to pull out a journal and thoughtfully write three paragraphs. You’ll grab your phone, hit record, and talk for 20 seconds. Done.

Because it captures the moment. Your emotion in your voice. The context you might forget later. The specific details that disappear when you try to remember retroactively. “I just got off the phone with my mom and I want to throw something and I’m sitting in my car and I need a cigarette” tells you way more than later writing “3pm - stress - mom.”

Because you can do it anywhere. Sitting in traffic, standing outside your office, lying in bed at 2am. No pen, no paper, no obvious recording behavior that makes people ask questions.

How to Set This Up

Use whatever tracking method works for you:

• Your phone’s built-in voice recorder

• A note-taking app if you prefer typing quick entries

• A voice-to-text feature if you want it automatically transcribed

• Written diary if that’s more your style

• Apps specifically designed for smoking cessation tracking

The key is zero friction. If you have to unlock your phone, find an app, navigate three menus—you won’t do it when a craving hits.

What to Track When a Craving Hits

You don’t need a script, but here’s what you want to capture:

• What time is it?

• What were you just doing?

• Who are you with (or are you alone)?

• What are you feeling? (Be specific: not “stressed” but “pissed off about that email from my boss”)

• How strong is this craving? (1-10 scale)

• Did you smoke or resist?

• If you resisted, what helped?

Real examples I’ve heard in clinic:

“7:15am, making coffee, alone in kitchen, feeling anxious about today’s presentation, craving is like 8 out of 10, I smoked”

“2pm, just got off a call with my aunt, sitting in my car in the grocery store parking lot, feeling angry and helpless and criticized, craving 9 out of 10, didn’t smoke, went for a walk around the parking lot instead”

“10pm, watching TV after kids are in bed, not stressed just bored and restless, moderate craving maybe 5 out of 10, smoked without really thinking about it until it was already done”

Notice the difference in detail? These aren’t generic. These are specific moments with specific contexts.

How Long to Track

At least one week. You need at least a full week to see if there are day-of-week patterns (Mondays are harder, weekends are different, Sunday night is terrible).

Better to do two weeks. This lets you see if patterns repeat or if last Tuesday was just a weird day.

Best if you include both normal weeks and high-stress events. If you’re tracking during a calm week, you might miss your stress triggers. If you’re only tracking during crisis mode, you might miss your routine autopilot cigarettes.

You need enough data to see patterns, not just random events.

How to Analyze Your Smoking Trigger Log: What Patterns to Look For

After a week or two, sit down and actually listen to your recordings (or read your notes). This part takes an hour, but it maybe the most important hour of your quit attempt.

Time patterns:

Are there times of day that consistently show up? The 7am coffee cigarette. The 3pm slump. The 10pm wind-down. These time-based triggers are often the easiest to prepare for because they’re predictable.

Do weekdays and weekends look different? A lot of people discover that work stress triggers them during the week but they barely think about smoking on Saturday morning. Or vice versa—weekend boredom may be the real enemy.

Emotional triggers - getting specific:

Go through and highlight every emotion word you used. Not just “stress” - what kind of stress? Anxiety about the future? Frustration with people not doing their job? Overwhelm from too many tasks?

I have a patient whose data showed she smoked when she felt criticized (by her husband and her boss) but not when she felt anxious or sad. That’s incredibly specific and incredibly useful information. She prepared for phone calls with her boss. She practiced responses to her husband’s comments. She recognized the pattern and could name it when it hit.

Social triggers:

Which names show up repeatedly? Is there a specific person who consistently appears in your craving logs? Sometimes it’s “after talking to my brother.” Sometimes it’s “alone after everyone leaves.” Sometimes it’s “at my friend’s house where I used to always smoke.”

Environmental and activity triggers:

Where are you when cravings hit? In your car? On your porch? At your desk? After you eat? While you’re drinking coffee?

One patient’s data showed he smoked every single time after he exercised. Not before, not during, only after. He’d created an association between “workout done” and “reward cigarette” so strong that he never consciously noticed it. Once he saw the pattern, he could plan for it.

Physical vs. behavioral - the critical distinction:

If your cravings are hitting you at random times throughout the day with no consistent pattern, that’s physical nicotine withdrawal. It peaks in the first 3-5 days and gradually decreases over weeks.

If your cravings are consistently tied to specific times, places, people, or activities—that’s behavioral conditioning. Those patterns can last for months or years after you quit because they’re habits, not chemical dependency.

You need different strategies for each. Physical withdrawal you manage with medication support (chantix, bupropion, or nicotine replacement). Behavioral triggers you need to prepare for differently.

Common Smoking Trigger Patterns: What Most Quitters Find When They Actually Track

After doing this with hundreds of patients, here are the patterns that show up most often:

The autopilot cigarettes. These are the ones you smoke without thinking. After every meal. With every cup of coffee. Every time you get in the car. You’ve done it so many thousands of times that your hand reaches for the cigarette before your brain even registers the thought.

The emotional regulation cigarettes. These are the ones that follow a specific feeling. Anger at your boss. Anxiety before a difficult conversation. Frustration with your kids. Overwhelm at your to-do list. You’ve trained your brain that “this feeling = cigarette = feeling better” (even though the cigarette doesn’t actually fix the feeling, just gives your brain something else to focus on).

The social cigarettes. Even people who say “I’m not a social smoker” usually find some social pattern. Talking on the phone with a specific person. After your spouse goes to bed and you’re finally alone. During work breaks with coworkers. At family gatherings where you feel judged.

The transition cigarettes. These mark transitions between parts of your day. Getting home from work. Before bed. After waking up. Starting a task you’ve been avoiding. Finishing something difficult. Your brain uses them as punctuation marks.

The procrastination cigarettes. You smoke to avoid starting something you don’t want to do. Before opening your laptop. Before making a phone call. Before starting that project. The cigarette becomes a delay tactic your brain has learned to deploy automatically.

How to Build a Personalized Quit Plan From Your Trigger Map

This is where it gets practical. You’re not mapping your triggers for fun. You’re creating a specific action plan—and sharing it with your doctor or healthcare provider.

Important: Bring this trigger map to your appointment. Your patterns will help them recommend the right combination of treatments. For example:

• If you have strong physical cravings throughout the day, you probably need medication (chantix or bupropion work differently than nicotine replacement)

• If you have specific emotional triggers, you might benefit from formal behavioral counseling or therapy

• If you have intense time-based triggers, extended medication use (beyond the standard 12 weeks) might help prevent relapse

Identify your highest-risk situations:

• Which triggers show up most often?

• Which ones are strongest (highest numbers on your 1-10 scale)?

• Which ones do you have the most control over?

• Which ones are hardest to avoid?

Develop specific strategies for YOUR specific triggers.

Not generic advice. Not “avoid stress.” Specific responses to specific patterns.

Example: Your data shows you smoke every day at 3pm at your desk when you hit the afternoon energy slump.

Strategies:

• Set alarm for 2:50pm, go for 10-minute walk before the craving hits

• Switch to a different location at 3pm (break room, outside, different floor)

• Have a specific alternative ready (nicotine gum, hard candy, cold water)

• Schedule your most engaging task for 3pm so you’re focused, not bored

Example: Your data shows you smoke whenever you feel criticized by your aunt, usually during/after phone calls.

Strategies:

• Limit phone calls to times when you can immediately do something physical afterward (walk, workout, chores)

• Have a script ready: “Mom, I need to go, I’ll call you later” when conversation goes south

• Call your support person immediately after talking to mom (or use a quitline coach: 1-800-QUIT-NOW)

• Write down your “why I’m quitting” and read it before calling her

Example: Your data shows you always smoke after dinner while watching TV.

Strategies:

• Change location (watch TV in bedroom instead of living room where you always smoked)

• Change timing (go for walk immediately after dinner, watch TV later)

• Change activity (do something with your hands - fold laundry, play phone game, knit)

• Remove environmental cues (lighter and ashtray put away in different room)

See how specific this is? You’re not trying to “reduce stress” or “avoid triggers.” You’re building a system where you’ve identified your exact high-risk moments and prepared exact responses.

Why Trigger Management Requires a System, Not Willpower

Saying “I won’t smoke when I’m stressed” is a goal. It requires willpower every single time stress hits.

Building a system looks like:

1. Identifying that your stress trigger is specifically Sunday evening dread about the work week

2. Scheduling something you enjoy every Sunday evening (dinner with friend, favorite show, video call with someone who makes you laugh)

3. Preparing your Monday the night before so there’s less to dread

4. Having your replacement behavior ready (walk around the block, text your quit buddy, use nicotine gum)

The system removes decisions in the moment. You’re not trying to willpower your way through. You’ve already decided what you’ll do when this specific trigger hits.

The Reality Check

You won’t avoid all triggers. Life doesn’t work that way. Your boss will still piss you off. Your aunt will still criticize you. You’ll still get stuck in traffic. The goal isn’t to live a trigger-free life (impossible). The goal is awareness and preparation.

Some triggers will surprise you even after you’ve mapped everything. You’ll hit week three of quitting and discover a trigger you never noticed before because it only happens once a month.

This isn’t a one-time exercise. It’s an ongoing process of noticing, mapping, and adjusting your strategies.

What If Patterns Aren’t Clear?

Some people track for two weeks and see crystal-clear patterns. Others see randomness.

If your patterns aren’t obvious:

• Keep tracking longer (you might need more data)

• Your triggers might actually be less predictable (which is useful information too)

• Random triggers need different strategies than predictable ones

Random/unpredictable triggers mean you need to focus more on general coping skills and medication support rather than avoiding specific situations. You can’t prepare for what you can’t predict, so you prepare to handle anything—and that’s where pharmacotherapy becomes especially important.

Next Steps Beyond Trigger Mapping

Understanding your triggers is a first step in your quit plan, but not the only one. You still need healthcare provider support to discuss other smoking cessation resources (medications such as chantix or behavioral counseling)- we will cover that in the next part of the series.

How This Fits With the Rest of the Series

Your why (Part 2) is what gets you through the triggers. When a craving hits and you want to cave, your specific, personal why is what you hold onto.

Your trigger map (this part) tells you which resources you need and helps your doctor recommend the right treatment combination.

Your next step (Part 4) is figuring out which cessation resources are actually worth your time and money. Spoiler: some work great, others not so much.

But first: map your triggers. One to two weeks. Real-time tracking. Your specific patterns. Then take that information to your healthcare provider and build a comprehensive quit plan.

Disclaimer: This article provides education about behavioral strategies for smoking cessation. It is not a substitute for medical advice. Consult your healthcare provider about medications and developing a comprehensive quit plan tailored to your situation. The combination of behavioral strategies, medication, and professional support provides the best chance of successfully quitting smoking. Patient examples in this article are composites drawn from years of clinical practice. Details have been changed to protect privacy. No individual patient is identifiable.

I explore in Part 1 why our current best treatment paradigm to help people quit fails ~75% of the time and why you must start with a crucial first step- Finding Your Why

Last week, I saw a COPD patient in clinic - let’s call him Mr. Smith. He’d been coughing and short of breath for about a year. His wife finally convinced him to see me.

We’d already talked about what COPD is - a chronic lung disease caused by smoking. As we started reviewing his recent lung function test results showing his lungs were getting worse, his wife jumped in.

“He needs to quit smoking! He can barely breathe walking to the mailbox. Now our son started smoking too. I want them both to quit!”

Mr. Smith sat quietly, arms folded, looking at the floor.

I turned to him. “What do you think, Mr. Smith?”

After a pause, he grunted: “Sure, I guess I should.”

I didn’t push smoking cessation strategies during this visit. Mr. Smith’s halfhearted response already told me everything I needed to know - this quit attempt would likely fail.

Why? Because we were talking about his wife’s reasons for wanting him to quit, not his own reasons.

That’s the problem. Finding someone else’s why is easy. Finding your own why - that’s a different ballgame entirely.

Why "I Want to Be Healthier" Fails as a Reason to Quit Smoking

Here’s what happens majority of the time- I ask why someone wants to quit, and they say some version of “it’s bad for my health.” In 2025, everyone knows smoking isn’t good for you, we are not in 1925. We’ve had public anti-smoking campaigns for decades now. If “smoking is bad for you” was a strong enough motivator, most would have quit years ago.

The research backs this up. Studies on motivation for behavior change consistently show that intrinsic motivation—reasons that come from your own personal values and desires—leads to better long-term success than extrinsic motivation, which is stuff like social pressure or general health concerns¹². Intrinsic motivation is what keeps you going when you’re trying to quit and on the edge, when that voice in your head is screaming for just one cigarette.

So when I ask “why do you want to quit?” and someone says “for my health” or “my wife wants me to quit”, what they’re really saying is “I don’t actually have a compelling reason yet, but I know that’s what I’m supposed to say.”

And that’s okay! That just means we’re still in the early contemplation stages. We haven’t found the real why yet.

Why Your Reason to Quit Smoking Needs to Be Specific

Your why has to be specific. Not specific like a SMART goal from some corporate training manual, but specific enough that you can picture it.

Let me give you examples from what some patients have said:

Not “I want to be healthier”, but “I want to walk my daughter down the aisle without needing my oxygen tank”

Not “My family wants me to quit”, but “My five-year-old granddaughter asked me why I smell bad and I realized I don’t want that to be her childhood memory of me”

Not “Smoking is expensive”, but “I’m spending $280 a month on cigarettes and I want to pay off my credit card debt”

See the difference? The specific why resonates differently. They’re not abstract future outcomes—they’re real and matter to you personally, emotionally.

There’s actual evidence for this. Goal-setting research shows that vague goals like “I want to exercise more” fail way more often than specific ones like “I will run three times a week and run a 5K in 6 weeks”³. The same principle applies to finding your why.

The Morning Coffee Test

I tell my patients to use what I call the morning coffee test. If you’re a smoker, that first cigarette of the day, usually with coffee or right after waking up is probably your strongest craving. Your brain has been without nicotine for 8 hours and it wants it asap.

So your why has to be strong enough to beat that craving. If thinking about your why doesn’t make you want to skip that cigarette more than you want to smoke it, it’s may not be specific enough yet.

This is uncomfortable to think about because it means most of our initial reasons aren’t good enough. “I should quit for my health” is not going to win against “oh my god I need a cigarette right now, I’m so stressed” But “I promised my grandkid I’d be at her high school graduation” might.

My Actual Process (The Messy Version)

Let me dive deeper into my weight loss journey, the parts I didn't cover in Part 1.

When my son was born, I didn’t suddenly have an epiphany and lose 25 pounds. That’s not what happened. What actually happened was I spent about six months being mad at myself for gaining weight, trying random diets for a week at a time, and generally feeling like crap about how I looked in photos.

My initial why was “I’m a doctor, I should know better than to be overweight.” That got me nowhere except more stressed, which made me eat more.

Then one night I was lying in bed scrolling through photos from my son’s first birthday party. And there’s this shot of me holding him, and I just looked...exhausted. Physically present but not really there. And I thought: in twenty years when he looks at photos from his childhood, is this who he’s going to remember? This tired, checked-out version of me?

That hit differently than “obesity increases cardiovascular risk.”

But even then, it wasn’t a straight line. My real why evolved over time. At first it was “I want to be present for my son.” Then it became more specific: “I want to have enough energy to play with him without getting winded.” Then even more specific: “I want to be able to pick him up and spin him around when he’s seven without my back going out.”

See what I mean? Your why isn’t usually a single lightbulb moment. It’s more like gradually adjusting the focus on a camera until the image gets clear.

How to Find Your Personal Reason to Quit Smoking: A Step-by-Step Framework

Here’s a framework that works:

Think about a specific moment. Not “my health in the future” but a real situation- Your daughter’s wedding. A vacation you want to take. That time your grandkid wrinkled their nose when you tried to hug them.

Ask yourself: what would I miss if I kept smoking? This is more powerful than “what will I gain if I quit.” What moments won’t happen? What experiences won’t be the same? Who will you hurt? Be specific. Not “I might die early” but “I might not be around when my son has his first kid.”

Notice what makes you actually angry. Not disappointed in yourself, but angry. Are you pissed off that you’re spending $300/month you don’t have? That you’re hiding it from people? That you can’t go two hours without needing to step outside? Anger can be intrinsic motivation.

Write it down somewhere you’ll see it. And I mean actually write it, by hand on paper. There’s research showing that handwriting goals makes them more effective than typing them⁴, probably because it forces you to slow down and actually think about what you’re writing. Put it somewhere you’ll see it every day. Your bathroom mirror. Your wallet. Your phone lock screen.

Can Your Reason to Quit Smoking Change Over Time?

One last thing: your why doesn’t have to be permanent. Maybe you start with “I want to save money” and later it evolves to “I want to be around to see my grandkids.” Maybe it’s “I’m sick of smelling like an ashtray” and then becomes “I want to be there to walk my daughter down the aisle.”

That’s normal. The contemplation stage isn’t a one-time event—it’s ongoing. You can keep refining your why as you go.

Because here’s the thing: I can prescribe you chantix. I can refer you to behavioral counseling. I can give you a detailed quit plan and coping strategies and rest of the evidence-based interventions modern medicine has to offer.

But none of that works if you don’t start with your why.

That’s step one.

Everything else comes after.

In the next part of this series, I’ll get into why goal setting isn’t enough. Next you have to put systems in place to get to your smoke-free destination.

Subscribe now

Share

References:

1. Curry S, Wagner EH, Grothaus LC. Intrinsic and extrinsic motivation for smoking cessation. J Consult Clin Psychol. 1990;58(3):310-316.

2. Brown N, et al. Differences and interactions between intrinsic and extrinsic motivations that drive smokers to quit and to continue smoking: a qualitative analysis. J Subst Use. 2024.

3. Shilts MK, Horowitz M, Townsend MS. Goal setting as a strategy for dietary and physical activity behavior change: a review of the literature. Am J Health Promot. 2004;19(2):81-93.

4. Mueller PA, Oppenheimer DM. The pen is mightier than the keyboard: advantages of longhand over laptop note taking. Psychol Sci. 2014;25(6):1159-1168.

And I don’t mean “we” as in individual doctors aren’t trying hard enough. I mean modern medicine, with our package of evidence-based interventions, kind of sucks at this. Even when we throw everything we have at smoking cessation—chantix, nicotine patches, wellbutrin, intensive counseling—only about 25% of people successfully quit¹. That’s our best package deal.

If you try to quit on your own, without any help or medications? You’re looking at 3-6% success rates². And most smokers try to quit 8 to 10 times before they actually succeed³.

Subscribe now

Why Smoking Cessation Treatments Fail — Even When Used Correctly

The medications only do so much. Chantix, our best medication, works by blocking nicotine receptors in your brain. It helps with cravings. But it doesn’t fix the 20-year habit of reaching for the cigarette when stepping outside after lunch, getting together with friends who also smoke or when you’re stressed. The nicotine addiction is only part of the equation.

Counseling is great in theory, terrible in practice. Behavioral therapy works—when people actually show up for it. Less than a third of smokers who try to quit use any counseling at all⁴. Counseling programs may not always be easily accessible. You have to make time for weekly or biweekly appointments. There’s variability in counselor experience and ability to build trust and rapport. We developed a clinician led (with smoking cessation training certification) smoking cessation program in our health system two years ago with mixed results. Lot of no-shows or loss to follow-up and quit rates around 15%.

Insurance coverage is lacking. Most plans cover some sort of smoking cessation, but the details of how many sessions or coverage of cessation medications vary. Medicare for example covers 8 sessions every year. Nearly 30% of smokers don’t have health insurance at all⁵.

We treat nicotine addiction like a simple habit to break. The reality- it’s a chronic relapsing disease that has a component of nicotine dependence and a component of learned behaviors that often hijacks your brain’s reward pathways. But we give people a 12-week prescription of medications and wish them luck. Sometimes they are lucky to get a few sessions of behavioral counseling to go with that. Its almost like giving someone with diabetes insulin for three months and saying “good luck, hope your pancreas figures itself out!”

Social and environmental triggers are everywhere. You can take all the chantix in the world, but if your spouse is a smoker, if you live with other smokers, if all your friends smoke, if your job is high-stress and everyone takes smoke breaks—you’re fighting an uphill battle. Stress itself is a big trigger and prevents people from quitting.

We don’t often address the Why. And this is the big one. The one we really need to talk about since it is essential to start the smoking cessation journey.

What Is a "Why" for Quitting Smoking and Why Does It Matter?

There’s this Nietzsche quote that Viktor Frankl loved to use: “He who has a why to live for can bear almost any how.”

I think about this quote all the time when I’m sitting across from patients in my clinic. Because the reality is, none of the medications we prescribe, quit plans we discuss, coping strategies we teach matter, if you don’t have a why.

Not my why. Not the Surgeon General’s why. Not even the “you’ll get lung cancer” why that you already know. Your why. The deeply personal, specific, visceral reason that makes quitting worth the absolute hell of nicotine withdrawal and then sustainable behavioral and lifestyle changes.

This is where the stages of change model becomes really important. Before anyone can quit and before any intervention can work, they have to move through two critical stages:

Precontemplation: You’re smoking, and you’re not really thinking about quitting. You know it’s bad for you. Maybe you’ve had a doctor mention it. But it’s not on your radar as something you’re going to address.

Contemplation: You’re starting to think about quitting. You’re weighing the pros and cons. You’re maybe looking up information online at 2 am. This is where the internal shift starts to happen—where you start developing your personal why.

You cannot skip these stages. You can’t force someone from precontemplation into contemplative and then to action. I’ve tried and it simply doesn’t work.

The why has to be personal. It can’t be abstract. “I should quit because it’s healthy” doesn’t cut it. But “I need to be around to walk my daughter down the aisle” might. “I’m sick of my grandkids wrinkling their noses when I hug them” might.

A Personal Confession

I want to be honest with you about something. I’m a doctor who is telling people how to change their health behaviors on a daily basis. And a few years ago, I completely lost control of mine.

It started small—stress eating during fellowship training, grabbing whatever was quick on a busy clinic day or on call night. Then my wife got pregnant with our first kid. Then my mom got sick with a neurologic condition. And I was balancing work and family care-giving and about 4 hours of sleep a night. I gained 25 pounds without really noticing.

The wake-up call came when I saw a photo of myself holding my newborn son. I didn’t recognize myself. And I thought: is this who I want him to remember? This exhausted, unhealthy version of me who’s too tired to play with him?

That was my why. Not “obesity increases cardiovascular risk” or any of the medicine I already knew. My why was: I want to be the dad who can keep up with my son as he grows up. I want to be around for a long time. I want him to see me taking care of myself so he learns to do the same.

It took me 2.5 years to lose those 25 pounds. It wasn’t linear. It wasn’t easy. But I had my why, and it got me through the hard days when I wanted to order pizza instead of cooking, when I wanted to skip the gym because I was exhausted.

Finding your why is step one. It’s the contemplation stage. It’s the foundation everything else is built on.

And if you’re reading this and you smoke, and you’re not quite ready to quit yet, that’s okay. You’re allowed to take your time. But maybe start thinking about your why. What would make it worth it? What would make you willing to go through nicotine withdrawal, to break decades-old behavioral patterns, to try up to 9 or 10 times to quit- if that’s what it takes?

Because once you find it, really find it—that’s when the medications and counseling and all our interventions actually have a chance at working.

Subscribe now

References:

1. Fiore MC, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services.

2. Babb S, et al. MMWR Morb Mortal Wkly Rep. 2017;65:1457-1464.

3. Centers for Disease Control and Prevention. Smoking Cessation: Fast Facts. 2022.

4. Babb S, et al. Quitting Smoking Among Adults — United States, 2000–2015. MMWR. 2017;65(52):1457-1464.

5. Jamal A, et al. Current Cigarette Smoking Among Adults — United States, 2016. MMWR. 2018;67(2):53-59.

The answer is it depends on the biopsy findings and something called staging to figure out if the cancer has spread or not.

Let me walk you through what happens after we find a lung nodule, so you know what to expect if you or someone you love is facing this.

Step 1: Confirming It’s Cancer

Not every lung nodule is cancer. We need to biopsy and look under the microscope to know for sure.

For Maria, we did a CT-guided needle biopsy. She lay on the CT table while an interventional radiologist used real-time imaging to guide a thin needle through her chest wall, between the ribs, into the nodule. The whole procedure takes about 30 minutes. She went home the same day with a small bandage and instructions to take it easy.

Other biopsy options include navigation or robotic bronchoscopy, where we pass a thin camera through your mouth into your airways to reach the tumor, or surgical biopsy, where a surgeon removes a larger part of the lungs entirely. Surgical biopsies are uncommon in 2025, since we can biopsy most nodules from the outside by a radiologist or inside by bronchoscopy.

A pathologist then looks at the tissue under a microscope. They tell us if it’s cancer, what type, and increasingly important—what genetic mutations it has. This is very important information especially for treating more advanced cancers.

Step 2: Staging the Cancer

Once we confirm it’s cancer, we need to know how far it’s spread. This determines the overall treatment strategy.

Maria was sent to get a PET scan, which is a special type of CT scan with radioactive contrast that can localize and “light up” areas of the body where the cancer may have spread. We also did a brain MRI since lung cancer sometimes spreads there.

Maria’s results were reassuring: the tumor was confined to her lung. No spread to lymph nodes, no distant metastases.

Staging goes from 1 to 4:

- Stage 1: Small tumor, no lymph node involvement

- Stage 2: Larger tumor or nearby lymph nodes involved in the middle of the chest

- Stage 3: Spread to lymph nodes in the center or opposite side of the chest

- Stage 4: Spread to the other lung, causing fluid to build up around the lung or distant organs

Maria’s stage 1A cancer gave her the best possible prognosis.

Step 3: Planning Treatment

This is where a multidisciplinary tumor board comes together and discusses patient cases to come to a consensus on best treatment strategy. Generally tumor boards are attended by thoracic surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, pulmonologists.

For Maria’s stage 1A lung cancer, the plan was clear: surgery.

When Maria met with our thoracic surgeon, the surgery was explained in detail. They’d remove the part of her lung containing the tumor—a lobectomy, taking out one of five lobes of her lungs. They’d also sample nearby lymph nodes to make absolutely sure the cancer hadn’t spread.

The surgery would be minimally invasive using small incisions and a camera. Recovery can take up to 4-6 weeks. Her remaining lung tissue would expand to fill the space.

Step 4: The Treatment Itself

Different stages and types require different approaches:

Early-stage non-small cell (stages 1-2): Usually surgery first. Sometimes radiation is considered instead if surgery isn’t safe due to patients having low lung capacity or other major health problems. Sometimes chemotherapy after surgery is recommended if there’s higher risk of recurrence.

Advanced non-small cell (stages 3-4): Usually a combination or chemotherapy and radiation therapy is offered. Surgery is often not an option. In 2025, all cancers are tested for mutations to figure out if immunotherapy or targeted therapy is an option.

Small cell lung cancer: Almost always chemotherapy and radiation because it spreads so early. Usually not treated with surgery.

Maria’s surgery went well and the surgeon was able to get clean margins, meaning no cancer cells were seen at the edge of the removed tissue. The lymph nodes were negative. No further treatment needed—just regular scans to monitor for recurrence.

Step 5: Follow-Up and Surveillance

This is essentially lifelong. Even after successful treatment, we watch carefully.

Maria gets CT scans every six months for the first two years, then annually. We’re looking for any sign the cancer has come back or that a new lung cancer has developed.

If it does come back, we hope to catch it early again and treat as soon as possible. And in 2025 we have more treatment options than ever before, including targeted therapies and immunotherapies that didn’t exist even 5-10 years ago.

What If It’s Advanced

If Maria had stage 4 lung cancer instead of stage 1, the conversation would be very different. We’d focus on controlling the cancer rather than curing it. We’d test for targetable mutations. We’d discuss quality of life alongside treatment options.

But even advanced lung cancer has more hope than it used to. Targeted therapies can keep some cancers controlled for years with minimal side effects. Immunotherapy has the promise to turn some advanced cancers into more chronic manageable diseases.

Maria’s Perspective

Six months after surgery, Maria came in for her follow-up scan. Clean. No recurrence.

“I tell everyone now,” she said. “If you’re over 50 and you smoked, get screened. Don’t wait for symptoms like I would have if I hadn’t gotten pneumonia.”

She’s become an advocate. She understands that she got lucky—the pneumonia that led to the CT scan probably saved her life.

But she also knows that screening is designed to give everyone that same luck. To find cancer before symptoms, when treatment is most effective and cure is most likely.

Bottom line: The path from suspicious nodule to treatment involves confirming the diagnosis with biopsy, staging the cancer to see how far it’s spread, planning treatment based on type and stage, and then lifelong surveillance. Early-stage lung cancer like Maria’s is often curable with surgery alone. Advanced stage lung cancer requires a more complex approach including chemotherapy and radiation, but has better treatment options than ever before. The key is catching it early—through lung cancer screening or, like Maria, through lucky incidental imaging.

Subscribe now

Share

This is the unfortunate reality with lung cancer. Once you start developing symptoms, the cancer has probably gotten much bigger or spread.

The Classic Symptoms

A cough that won’t quit is the most common symptom. Not just any cough—one that lasts more than a month and isn’t getting better. Or a smoker’s cough that suddenly changes in character, gets worse, or produces blood.

Coughing up blood is always concerning. Even tiny streaks of blood in your phlegm should be evaluated by a doctor. It doesn’t always mean cancer, but we need to rule it out.

Shortness of breath that’s new or getting worse, especially if you can’t explain it with other health problems. You used to walk up stairs fine, now you’re winded halfway up.

Chest pain that’s persistent. Lung cancer can invade the chest wall or irritate the lining around the lungs. The pain might be dull and constant, or sharp when you take a deep breath.

Unexplained weight loss of 10 pounds or more without trying. Your appetite might be gone, or food just doesn’t taste right anymore.

Hoarseness or voice changes that last more than two to three weeks. A tumor near your vocal cords can affect the nerve that controls your voice box.

What we need to highlight with all these “classic symptoms” is there are a multitude of other medical conditions that can cause them, it is not always cancer.

The Sneaky Symptoms

Some symptoms from lung cancer may not seem related to your lungs at all and are easy to miss.

Bone pain, especially in your back or hips, can mean the cancer has spread to your bones.

Headaches that are new, persistent, or come with nausea and vision changes could indicate spread to the brain.

Swelling in your face, neck, or arms can happen when a tumor presses on the large vein that returns blood from your upper body to your heart. This is called superior vena cava (SVC) syndrome.

Frequent infections like pneumonia or bronchitis that keep coming back in the same part of your lung might indicate a tumor blocking an airway.

Clubbing of fingernails—when your fingertips and nails look rounded & bulbous appearance—can be a sign of lung cancer or other serious lung disease.

When Early Lung Cancer Has Symptoms

Sometimes early-stage lung cancer can cause symptoms, usually because of the cancer’s location.

A tumor in a main airways in the middle of the chest might cause coughing or wheezing early on, even when it’s small. A tumor near the chest wall might cause pain before it spreads. A tumor that partially blocks a smaller branch of the airways can lead to recurrent pneumonia in that area.

But most cancers in the outer parts of the lung—like Maria’s adenocarcinoma—often grow silently. There are no pain receptors in most of the lungs, so often you don’t feel anything until the tumor gets large enough to press the lining of the lung.

While we do want to be aware of possible symptoms of lung cancer, the big take home message remains - early stage lung cancer most often has no symptoms at all. This is why lung cancer screening matters. You can’t rely on symptoms to catch it early.

What Maria Teaches Us

Maria’s case reminds us that early lung cancer often has no symptoms. She felt completely fine until she got pneumonia that led to a CT scan. The cancer was pretty small, hadn’t spread, and was completely curable with surgery.

If she had waited until she developed symptoms, the cancer might have grown larger or spread. Her treatment would have been more complicated, her prognosis worse.

After her surgery, Maria told me she’s telling all her friends over 50 who used to smoke to get screened. “I was lucky,” she said. “But you can’t count on luck.”

She’s right. Screening finds cancers long before symptoms appear. But if you do have concerning breathing related symptoms—especially if they persist or worsen—don’t wait. Talk to your doctor to get checked out.

Subscribe now

Share

Leave a comment

Bottom line: Most early lung cancers cause no symptoms, which is why screening is critical. When symptoms do appear, the most common are persistent cough, shortness of breath, chest pain, and unexplained weight loss. Any symptom that persists beyond a few weeks or worsens deserves to be checked out. Don’t assume it’s nothing—Maria’s cancer was found by accident, but many people aren’t that fortunate.

“If I’d never had that pneumonia and then CT scan done, would you have found this cancer in time?”

To be honest, probably not. Her tumor was small and she did not have any symptoms. Without that CT scan for pneumonia, we might not have caught the cancer until it was much larger, spread to other parts of her body and much harder to treat.

Now we do have lung cancer screening, especially for high risk patients…it’s just that most may not know about it or get it done.

What Lung Cancer Screening Actually Is

Lung cancer screening uses a low-dose CT scan of your chest. No contrast dye, no needles, takes under a minute. You hold your breath, the scanner takes detailed pictures of your lungs, and we look for any suspicious spots.

It’s similar to mammograms for breast cancer or colonoscopies for colon cancer—we’re looking for early cancer before you feel sick.

The key difference from a regular chest X-ray: CT scans can find tumors when they’re much smaller. We’re talking tumors the size of a grain of rice that wouldn’t show up on an X-ray for months or even years.

Who Should Get Screened

The current screening guidelines from the US Preventive Services Task Force say you should get screened if you meet ALL of these criteria:

- Age 50-80 years old

- Current smoker OR quit within the past 15 years

- Smoking history of at least 20 pack-years

Pack-years sounds complicated but it’s simple math: packs per day multiplied by years smoking. One pack a day for 20 years equals 20 pack-years. Two packs a day for 10 years also equals 20 pack-years.

If you’re 55, smoked a pack a day from age 25 to 45, then quit 10 years ago, you qualify. Your 20 pack-year history puts you at higher risk even though you quit.

Why These Specific Criteria

The age and smoking criteria identify people at highest risk. About 80% of lung cancers occur in people who are or were cigarette smokers, and risk increases with age and how much you’ve smoked.

People outside these criteria can still get lung cancer. Actually 20% of lung cancer patients never smoked. But screening everyone would lead to probably too much extra radiation or cost; and too many false alarms and unnecessary biopsies of harmless nodules. As of 2025, we do not have a reliable way to balance these benefits and risks- something I’ll cover in a future article.

What Happens During Screening

You show up to the radiology department. No prep is needed, no fasting, no need for an IV or contrast.

You lie on the table and raise your arms above your head. The scanner looks like a giant donut. The table slides you through while you hold your breath for about 10 seconds. That’s it.

The radiation dose is about one-tenth of a regular diagnostic CT scan—roughly the same amount of radiation you’re exposed to from your environment over a few months.

When We Find Something

Here’s what most people don’t realize: we find nodules or spots on about 25% of screening scans. The vast majority aren’t cancer.

Most are old scars from infections you had years ago. Some are lymph nodes. But we do track them over time to see if they grow.

If a nodule does look suspicious—wrong shape, wrong density, growing when we compare to old scans—then we do more testing. Maybe another CT in three months. Maybe a PET scan to see if the nodule is metabolically active. If suspicious enough, we biopsy it.

Maria’s nodule was found incidentally, not through screening. But the our treatment strategy would have been the same if it had been caught on a screening scan.

The Evidence Screening Works

A major study called the National Lung Screening Trial (NLST) showed that annual low-dose CT screening reduces lung cancer deaths by 20% in high-risk people compared to chest X-rays.

Twenty percent might not sound huge, but it translates to thousands of lives saved each year. We often catch cancers at stage 1 instead of stage 3 or 4. Surgery instead of chemotherapy. Cure instead of palliative care.

Why People Don’t Get Screened

Despite the evidence, only about 5-15% of eligible people get screened. Some don’t know they qualify. Some are scared of what we might find. Some quit smoking years ago and don’t think they’re still at risk. Many healthcare providers are not up to date on the criteria or simply don’t have the time to discuss it during visits.

So if you or someone you know smoked for about 20 years, talk to your healthcare provider about lung cancer screening. It’s usually covered by insurance with no copay.

Bottom line: Lung cancer screening finds cancers early when they’re most treatable or curable. If you’re 50-80 with a significant smoking history (about 20 years), you should be getting screened annually. Maria’s cancer was caught by accident, but screening is designed to catch these tumors before they cause any symptoms—and when the treatment works best.

Subscribe now

Share

She looked at me across the exam room. “What’s the difference? Cancer is cancer, right?”

Not exactly. The type of lung cancer you have completely changes the treatment plan, prognosis, and what the next few months look like.

Small Cell vs. Non-Small Cell

When we look at lung cancer cells under a microscope, they fall into two main categories based on how they look and behave.

Small cell lung cancer (SCLC) makes up about 10-15% of cases. The cells are small, grow incredibly fast, and spread early. By the time we find it, it’s usually already spread beyond the lungs. Small cell lung cancer is almost always caused by smoking.

Non-small cell lung cancer (NSCLC) represents the rest of the cases—about 85-90% of lung cancers. The cells are larger, grow slower than small cell, and we often catch them before they spread. This is the type Maria had.

Why Small Cell Is Different

Small cell lung cancer is aggressive. It doubles in size as quickly as 25-30 days compared to non-small cell cancers which usually takes months. If you find a small cell tumor today and wait three months, it could be much much larger.

Because it grows and spreads so fast, surgery usually isn’t an option. The cancer has typically already spread to lymph nodes or other organs by the time we diagnose it. Treatment is chemotherapy and radiation, and we start as soon as possible.

The strange thing about small cell? It responds really well to chemotherapy at first. The tumors shrink dramatically. But unfortunately it almost always comes back.

The Three Types of Non-Small Cell

Non-small cell lung cancer breaks down further into three sub-types:

Adenocarcinoma (40% of lung cancers) - Starts in the cells that make mucus. Most common in women, non-smokers, and younger people. Usually found in the outer parts of the lungs. This is what Maria had.

Squamous cell carcinoma (25-30% of lung cancers) - Starts in flat cells lining the airways. Strongly linked to smoking. Usually found in the central airways near the middle of the lungs.

Large cell carcinoma (10-15% of lung cancers) - Can appear anywhere in the lung. Tends to grow and spread faster than the other two types.

Why Maria’s Diagnosis Matters

Maria has adenocarcinoma, stage 1A. That means:

- The tumor is small (less than 3 cm)

- It hasn’t spread to lymph nodes

- It hasn’t spread to other organs

- We caught it early!

Her treatment will be surgery to remove the tumor and a small margin of healthy tissue around it. Because it’s stage 1A and hasn’t spread, she won’t need chemotherapy afterward.

If she had small cell lung cancer instead, we’d probably be talking about chemotherapy and radiation rather than surgery. The treatment approach would be very different.

What This Means for Treatment

Knowing the exact type and stage of lung cancer determines everything:

- Small cell almost always gets chemotherapy and radiation

- Early-stage non-small cell (like Maria’s) usually gets surgery first. In some patients so are too old or sick to undergo surgery, radiation therapy is a good secondary option.

- Advanced non-small cell cancers might get targeted immunotherapy if we find specific genetic mutations

Bottom line: The type of lung cancer matters because it tells us how the cancer behaves and what treatment strategy will work best. Small cell is aggressive but responds to chemotherapy. Non-small cell is slower-growing and often curable with surgery or radiation if caught early. For Maria, having stage 1A adenocarcinoma means excellent odds and curative treatment with surgery alone.

Subscribe now

Leave a comment

It’s this question (or some similar variation) I hear most often when seeing a referral for a lung nodule (a “spot” or “growth” in the lungs).

What Lung Cancer Actually Is

Your lungs are packed with millions of tiny air sacs and the tubes connecting them. Lung cancer happens when cells in those structures start growing out of control. Normal cells divide, do their job, and die on schedule. Cancer cells don’t follow the rules. They keep dividing, piling up, eventually turning into cancer.

I’ll sometimes tell patients to think of it like a copy machine gone haywire. Normal cells make a few copies of themselves, then stop. Cancer cells just keep hitting “print” and never stop.

Why It Happens

Smoking cigarettes is still the biggest cause worldwide- about 80% of lung cancers happen in current or former smokers. But that leaves 20%—one in five cases—in non-smokers who may have different risk exposures or due to genetics.

Other exposures include radon gas seeping into homes from the ground, secondhand smoke exposure, air pollution, asbestos, and family history.

The Numbers That Matter

Lung cancer is the leading cause of cancer death in the United States as well as worldwide, killing more people than colon, breast, and prostate cancer combined.

But here’s the hopeful part: when we catch it early—before it spreads—about 60% of people survive at least five years. In some very early cases, survival rates can be up to 90%. The challenge is most don’t have any symptoms in the early stages. No cough, no shortness of breath, no pain, nothing. That’s why lung cancer screening matters.

What Comes Next

Maria’s nodule was found by accident during a CT scan in the ER, evaluating for pneumonia. Because of the size of the nodule and her smoking history, Maria was referred to get a biopsy of the nodule.

In Part 2, I’ll go over the two main types of lung cancer. They behave completely differently, and knowing which type changes everything about treatment. For Maria, figuring out if this nodule is indeed cancer and what specific type it is will determine her eventual care plan.

Bottom line: Lung cancer happens when cells in your lungs grow out of control. Smoking causes most cases, but one in five people who get lung cancer were never smokers. Understanding the basics matters whether you’re a patient, a worried family member, or someone trying to separate facts from fear.

Subscribe now

Leave a comment

Lung Cancer Screening Rates Are Critically Low: What the Numbers Show

Only 1 in 5 Americans who should be getting lung cancer screening actually got it in 2024, according to the American Cancer Society. That’s millions of people who qualify for a simple screening test but aren’t getting it.

Here’s what that means in real numbers: if everyone who qualified got screened, we’d prevent 62,110 lung cancer deaths over five years instead of just 14,970. That’s more than three times as many lives saved.

How Does Lung Cancer Screening Compare to Other Cancer Screenings?

Compare lung cancer screening to other cancer screenings. About 76% of eligible Americans get breast cancer screening and 70% get colorectal cancer screening. But lung cancer? Only 19%. That means we’re missing the chance to save more than 47,000 extra lives over the next five years.

Why Early Detection Saves Lives in Lung Cancer

Lung cancer kills more Americans than any other cancer—about 125,000 people died from it in 2025. But when we catch it early with screening, people have a much better chance of beating it.

Early detection gives you up to 90% survival rate.

Think of it like this: finding lung cancer early is like catching a small fire before it spreads through your whole house. The earlier you spot it, the easier it is to stop.

Subscribe now

Share

Who Qualifies for Lung Cancer Screening?

You might need lung cancer screening if you:

• Are between 50 and 80 years old

• Have smoked cigarettes in your life

• Smoked a fair amount (what doctors call “20 pack-years”—more on that below)

What Is a Pack-Year? How to Calculate Your Smoking History

This sounds confusing, but it’s simple math:

• 1 pack a day for 20 years = 20 pack-years

• 2 packs a day for 10 years = 20 pack-years

• Half a pack a day for 40 years = 20 pack-years

What to Expect From a Lung Cancer Screening CT Scan

Lung cancer screening is just a quick CT scan of your chest. It’s:

• Painless

• Takes only a few minutes

• Covered by insurance (no cost to you under most plans)

• Can spot problems when they’re still small and treatable

Why Aren’t People Getting Screened?

There are real reasons:

• Many people don’t know they qualify

• Some doctors don’t always bring it up

• People feel embarrassed about their smoking history

• In some areas, it’s hard to find a place that does the test

• Fear of what they might find

How to Get Lung Cancer Screening: Next Steps

If you’re 50-80 and have ever been a smoker:

1. Talk to your doctor and ask: “Am I eligible for lung cancer screening?”

2. Don’t be embarrassed about your smoking history—your doctor just wants to help

3. Know it’s free under most insurance plans

4. Tell your friends and family who might qualify too

The Bottom Line

We’re missing a huge opportunity here. The technology exists. The test works. Insurance covers it. But 4 out of 5 people who should be getting screened aren’t doing it.

Every one of those numbers is a real person—someone’s parent, spouse, friend, or neighbor. Someone who could have years more of birthdays, holidays, and time with the people they love.

Take Action Today

If you think you might qualify, talk to your doctor this week. Just ask:

“Should I get screened for lung cancer?”

That one conversation could save your life.

Because catching cancer early isn’t just good medicine—it’s the difference

between life and death.

Subscribe now

Share

Leave a comment

Medical Disclaimer: This is educational content based on research and clinical experience. It is not personal medical advice. Always consult your healthcare provider before starting or stopping any treatment or seeking personalized medical care.

References

1. American Cancer Society. (2025, November 19). Latest ACS Lung Cancer Data: Only 1 in 5 Eligible Adults in U.S. Screened for Lung Cancer; 62,000 Lives Over 5 Years Could be Saved if All Eligible Screened.

https://pressroom.cancer.org/2025-lung-cancer-data

2. Bandi, P., Landy, R., Star, J., Kratzer, T., Smith, R., & Jemal, A. (2025). Lung Cancer Screening Uptake and Mortality Reduction. Journal of the American Medical Association.

https://jamanetwork.com/journals/jama/article-abstract/2841694

3. U.S. Preventive Services Task Force. (2021). Lung Cancer: Screening - Final Recommendation Statement.

https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening

4. Knudsen, A.B., et al. (2024). With More Cancer Screening, Fewer Deaths but also More Harms. National Cancer Institute - Cancer Currents Blog.

https://www.cancer.gov/news-events/cancer-currents-blog/2024/more-cancer-screening-modeling-study-knudsen

5. American Lung Association. Understanding the New Lung Cancer Screening Guidelines.

https://www.lung.org/blog/new-lung-cancer-screening-guidelines

6. Centers for Disease Control and Prevention. (2023). Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.

https://www.cdc.gov/pcd/issues/2023/23_0071.htm

7. HealthCare.gov. Preventive care benefits for adults - Lung cancer screening.

https://www.healthcare.gov/preventive-care-adults/

Tom, a 67-year-old with moderate COPD (chronic obstructive pulmonary disease—a progressive lung condition that makes breathing difficult), looked healthier than I’d seen him in two years. His breathing was easier, his cough had diminished, and he’d even started walking his dog again.

“What changed?” I asked, expecting to hear about him finally quitting smoking cigarettes or starting pulmonary rehab.

“Mullein tablets. My sister told me about them.”

His pulmonary function tests had actually improved—not dramatically, but measurably. So I did what any good doctor should do: I looked at the data.

What the Research Actually Shows

Let me be straight: There are no high-quality clinical trials on mullein for COPD. None.

Mullein (Verbascum thapsus) contains compounds that theoretically could have anti-inflammatory properties. We have some laboratory studies and centuries of traditional and folk medicine use, but that’s not the same as clinical evidence.

FACT-CHECK: Laboratory studies show anti-inflammatory properties in vitro. However, there are NO randomized controlled trials demonstrating efficacy for COPD in humans. A 2016 literature review found that the only clinical study ever conducted on mullein for respiratory conditions was from Dublin, Ireland in the early 1800s—and it only included seven patients.

So Why Did Tom Improve?

When I dug deeper, here’s what emerged:

Other changes he made: He’d cut smoking from 20 to 5 cigarettes daily, started the mullein when spring arrived (his COPD always improves with warmer weather), began daily walks, and became more consistent with his maintenance inhaler.

The placebo effect: Believing something will help produces real, measurable improvements. Studies show placebos can improve lung function (FEV1) by approximately 4.2% in asthma patients, with much larger effects (25-31%) on subjective symptoms like breathlessness.

Natural disease variability: Chronic lung disease symptoms fluctuate. Without controlled comparison, we can’t know if the supplement caused improvement or just coincided with it.

It might actually help (a little): I can’t rule this out. We just don’t have data to know for sure.

The Real Risks

Drug interactions: Mullein contains coumarins, which theoretically could increase bleeding risk when combined with blood thinners like warfarin.

Quality concerns: A 2013 study found 59% of herbal supplements contained plant species not listed on labels. A 2021 study found ~60% contained fungal isolates.

False security: My biggest concern is patients replacing proven treatments with unproven supplements. That’s dangerous.

What Actually Works for Chronic Lung Disease

Proven to help:

• Pulmonary rehabilitation programs

• Regular exercise and breathing techniques

• Vaccinations including flu and pneumoccocal

• Quitting smoking

Possibly helpful (some limited evidence):

• N-acetylcysteine (NAC)

• Vitamin D supplementation (if deficient)

• Omega-3 fatty acids

Unproven but low-risk: Mullein, if used alongside proven treatments

Six Months Later

Tom came back having stopped smoking completely and joined pulmonary rehab. He was still taking mullein. His lung function had improved another 8%.

“Is it the mullein?” he asked.

“Honestly? Probably not primarily. It’s more likely because you quit smoking and started rehab. But if you want to keep taking it and it’s not causing problems, I’m not going to tell you to stop.”

The Bottom Line

There’s no scientific evidence that mullein treats COPD or chronic lung disease. But there’s also limited evidence it causes harm when used sensibly alongside proven treatments.

If you have COPD or chronic lung disease:

1. Don’t replace prescribed medications with supplements

2. Talk to your doctor before adding anything new

3. Focus first on proven interventions

4. Monitor symptoms objectively if you try supplements

The most important thing Tom did wasn’t taking mullein. It was taking control of his health—walking daily, cutting out cigarettes, staying consistent with his medications.

Sometimes the supplement isn’t the medicine. The decision to take better care of yourself is.

Medical Disclaimer: This is educational content, not personal medical advice. Always consult with your health care provider before starting or stopping any treatments for medical conditions.

References

Mullein Background & Traditional Use:

• Turker AU, Gurel E. Common mullein (Verbascum thapsus L.): recent advances in research. Phytother Res. 2005;19(9):733-739.

• Blanco-Salas J, Hortigón-Vinagre MP, Morales-Jadán D, Ruiz-Téllez T. Searching for Scientific Explanations for the Uses of Spanish Folk Medicine: A Review on the Case of Mullein (Verbascum, Scrophulariaceae). Molecules. 2021;26(13):3798.

Clinical Evidence (Lack Thereof):

• Karman R. Assessing the Effectiveness of Mullein on Respiratory Conditions Such as Asthma. ResearchGate. 2016.

Placebo Effects in Respiratory Disease:

• Luc F, Stokes J, Azim A, et al. Placebo effects in clinical trials evaluating patients with uncontrolled persistent asthma. Ann Am Thorac Soc. 2019;16(12):1557-1563.

Supplement Quality & Safety Concerns:

• Newmaster SG, Grguric M, Shanmughanandhan D, et al. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222.

• Screening for consistency and contamination within and between bottles of 29 herbal supplements. PLoS One. 2021;16(11):e0260463.

• Risks and Benefits of Commonly Used Herbal Medicines in México. Toxins (Basel). 2008;5(6):1755-1771. PMC2322858.

NAC Evidence (for comparison):

• Cazzola M, Calzetta L, Page C, et al. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. Eur Respir Rev. 2015;24(137):451-461.

• Poole P, Sathananthan K, Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019;5(5):CD001287.

• Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD. Nat Commun. 2024;15:8327.

Treatment Guidelines:

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2024 Report.

Sarah walked into my office for her biannual checkup looking different. I couldn’t quite place it at first—then I realized: No cigarette smell. For the first time in four years.

“You quit?” I asked, already pulling up her chart. Two-pack-a-day smoker since age 19.

Multiple failed quit attempts with patches, gum, chantix. History of COPD with declining lung function. I’d been on her case for years.

“Four months now,” she said, grinning. “And I haven’t even thought about a cigarette in weeks.”

“What finally worked? Did you try the combination therapy I recommended?”

“Hypnosis. One session. I know it sounds crazy.”

As a pulmonologist, I hear about every alternative smoking cessation method imaginable. Hypnosis comes up from time to time—patients ask about it, friend-of-a-friend success stories circulate, and it’s heavily marketed as an easy, one-session cure. So I did what I always do: I looked at the actual research.

What Is Hypnotherapy for Smoking Cessation and How Does It Work?

Clinical hypnotherapy for smoking typically involves inducing a relaxed, focused state of attention where the therapist provides suggestions designed to: strengthen motivation to quit, reduce cravings, associate smoking with negative sensations, and reinforce identity as a non-smoker.

Sessions usually last 60-90 minutes. Some practitioners offer single-session treatments, while others recommend multiple sessions. Many teach self-hypnosis techniques for ongoing use.

The theory: By accessing the subconscious mind during hypnosis, you can reshape deeply ingrained behavioral patterns and emotional associations with smoking.

Does Hypnosis Work for Smoking Cessation? What the Research Shows

The short answer: hypnosis is not superior to behavioral counseling, and it is significantly less effective than combining medication with behavioral therapy.

The Cochrane Collaboration’s 2019 systematic review — the gold standard for medical evidence — analyzed randomized controlled trials of hypnotherapy for smoking cessation and concluded there is insufficient evidence to support hypnotherapy as a smoking cessation treatment superior to other treatments. When compared directly to behavioral counseling or brief interventions, hypnosis did not show statistically significant advantages. Individual studies showing benefits were small and had methodological weaknesses.

Clinical Trials on Hypnosis for Smoking: Key Study Results

1. The Veterans Affairs Trial (2008) - 286 smokers randomized to either hypnosis + nicotine patch or behavioral counseling + nicotine patch.

Results at 12 months:

• Hypnosis group: 20% quit rate

• Behavioral counseling: 14% quit rate

• Difference: NOT statistically significant (p-value indicated this could easily be chance)

One interesting finding: Among participants with depression history, hypnosis showed better results.

2. The Swiss Cluster Trial (2013)- 223 smokers receiving single-session group hypnosis vs. group relaxation.

Results at 6 months:

• Hypnosis: 14.7% quit rate

• Relaxation: 17.8% quit rate

• No significant difference (p=0.73)

3. The German CBT Comparison (2024)- 360 participants receiving 6 sessions of group hypnotherapy vs. cognitive behavioral therapy.

• Both approaches showed similar quit rates

• No clear advantage for hypnotherapy

FACT-CHECK: How does this compare to proven treatments?

Unassisted quitting (”cold turkey”): 3-5% success rate at 6 months

Behavioral therapy alone: 7-16% success rate

Nicotine replacement therapy (NRT): Increases quit rates by 50-70% over placebo

This means if 5% quit with placebo, NRT brings it to 8-9%

Varenicline (most effective medication): 32-53% success rate at 1 year

Combination therapy (medication + intensive behavioral counseling): Highest success rates

Some studies show up to 45-55% success with combined approaches.

Sources: Cleveland Clinic Journal of Medicine (2021); PMC Review of Smoking Cessation Interventions (2024)

So Why Did Sarah Succeed?

This is where clinical practice diverges from randomized controlled trials. When I dug deeper into Sarah’s story, here’s what I found:

1. Timing and Readiness

Sarah had just become a grandmother. Her daughter told her, “I won’t let you hold the baby if you smell like smoke.” She was more motivated than she’d ever been.

2. She Paid for It

The hypnosis session cost $300. Research shows that paying out-of-pocket for cessation treatment increases commitment and follow-through.

3. The Ritual and Ceremony

The hypnosis session felt significant—a formal declaration of change. This psychological marker can be powerful, regardless of the specific technique used.

4. Ongoing Support

The hypnotherapist taught her self-hypnosis techniques she practiced daily. This gave her a coping tool for cravings—functionally similar to the behavioral strategies we teach in cognitive behavioral therapy.

5. Previous Failed Attempts

Sarah had tried everything else. Sometimes success comes from exhausting all other options—the desperation itself becomes motivating.

Was it the hypnosis that worked? Or was it the combination of high motivation, financial investment, structured support, and a new approach after multiple failures?

The research suggests the latter.

Is Hypnosis Safe for Smoking Cessation? Risks, Limitations, and What to Expect

Here’s what I tell patients who ask about hypnosis:

1. It’s Not Harmful

Unlike some alternative therapies, hypnosis for smoking cessation appears safe. The main risks are: wasting money, delaying use of proven treatments, and false expectations.

2. It’s Not Better Than Standard Treatments

The evidence clearly shows hypnosis does not outperform behavioral counseling, and it’s definitely not as effective as combining medication with behavioral therapy.

3. Success Stories Don’t Equal Scientific Evidence

Yes, some people quit with hypnosis. Some people also quit cold turkey. The question isn’t “Does it ever work?” but “Does it work better than other approaches we could recommend?”

The answer is no.

4. If You Want to Try It, Do This:

• Don’t use it INSTEAD of proven treatments—use it ALONGSIDE medication and behavioral counseling

• Choose a licensed therapist (psychologist, licensed clinical social worker) with proper training

• Be skeptical of “one session cures” marketing

• Set a backup plan if it doesn’t work

• Don’t pay more than a few hundred dollars

5. What I Recommend Instead

The combination that has the strongest evidence:

• Medication: chantix (first choice), bupropion, or combination nicotine replacement therapy (patch + gum/lozenge)

• Behavioral support: Structured counseling program, either individual or group

• Duration: At least 12 weeks of medication, ongoing behavioral support

• Relapse prevention: Extended treatment and follow-up

This approach gives you the best statistical chance of success.

Why Do People Choose Hypnosis Over Proven Quit-Smoking Treatments?

Patients gravitate toward hypnosis because:

• It promises quick results - one session vs. weeks of treatment

• It seems “natural” - no medications or side effects

• It feels empowering - you’re using your own mind, not external drugs

• The marketing is compelling - success stories and testimonials

• It’s mysterious - tapping into subconscious power sounds appealing

I get it. After years of failed quit attempts, people want something different. Something that doesn’t feel like the same old advice. Hypnosis feels novel.

But here’s what we know from decades of research: Smoking cessation is hard not because you haven’t found the right trick—it’s hard because nicotine is profoundly addictive.

There’s no magic bullet. Not hypnosis, not acupuncture, not cold laser therapy. What works is:

1. Medications that reduce cravings and withdrawal

2. Behavioral strategies to manage triggers

3. Social support to maintain motivation

4. Time and repeated attempts

5. Professional guidance throughout the process

What Happened to Sarah?

Six months after that first smoke-free checkup, Sarah came in for follow-up. Still not smoking. Her lung function tests had stabilized—no further decline. She was walking two miles daily without getting winded.

“The hypnosis really worked,” she said.

I thought about telling her what the research shows—that hypnosis isn’t statistically superior to other approaches, that her success likely came from the confluence of high motivation, ritual, and structured practice, not from accessing her subconscious mind.

But I didn’t. Because here’s what I’ve learned after many years practicing medicine: Belief is powerful.

If Sarah believes hypnosis helped her quit, and that belief strengthens her resolve to stay quit—who am I to argue? The goal isn’t to prove what method she used. The goal is that she’s no longer smoking.

What I did say: “Whatever you’re doing, keep doing it. And if you ever feel yourself slipping, we have medications and additional support available. You don’t have to do this alone.”

She smiled. “My granddaughter just started walking. I plan to be around to see her graduate high school.”

Hypnosis for Smoking Cessation: What to Do Instead — and When to Consider It

Hypnosis for smoking cessation:

• Is not superior to behavioral counseling according to the best available evidence

• Is significantly less effective than combining medication with behavioral therapy

• May work for some people, but so does nearly every intervention (including placebo)

• Is not harmful when used by a qualified professional

• Should not replace proven treatments, but can be added if someone is highly motivated to try it

If you’re trying to quit smoking:

1. Start with what works best: Combination therapy (medication + behavioral counseling)

2. Choose FDA-approved medications: chantix, bupropion, or NRT

3. Get structured support: Quitline (1-800-QUIT-NOW), smoking cessation program, or regular counseling

4. Plan for multiple attempts: Most successful quitters tried 8-10 times before succeeding

5. If you want to try hypnosis: Use it as an add-on, not a replacement, and don’t delay

starting proven treatments

The most important message: If you smoke, quit. Use whatever combination of tools gives you the best chance of success. The method matters less than the outcome.

Your lungs will thank you.

Subscribe now

Share

Leave a comment

Medical Disclaimer: This is educational content based on peer-reviewed research and clinical experience. It is not personal medical advice. Always consult your healthcare provider before starting or stopping any smoking cessation treatment.

Evidence-Based References

Barnes J, McRobbie H, Dong CY, Walker N, Hartmann-Boyce J. Hypnotherapy for smoking cessation.

Cochrane Database Syst Rev. 2019;6(6):CD001008. oi:10.1002/14651858.CD001008.pub3

Carmody TP, Duncan C, Simon JA, et al. Hypnosis for smoking cessation: a Randomized trial. Nicotine Tob Res. 2008;10(5):811-818. doi:10.1080/14622200802023833

Dickson-Spillmann M, Haug S, Schaub MP. Group hypnosis vs. relaxation for smoking cessation in adults: a cluster-randomised controlled trial. BMC Public Health. 2013;13:1227. doi:10.1186/1471-2458-13-1227

Batra A, Eck S, Riegel B, et al. Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial. Front Psychol. 2024;15:1330362. doi:10.3389/fpsyg.2024.1330362

Hasan FM, Zagarins SE, Pischke KM, et al. Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: results of a randomized controlled trial. Complement Ther Med. 2014;22(1):1-8.

Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008.

Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11(11):CD000146.

Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5(5):CD009329.

A review of smoking cessation interventions: efficacy, strategies for implementation, and future directions. PMC. 2024;11(2):e54813.

The current state of tobacco cessation treatment. Cleve Clin J Med. 2021;88(7):393-402. doi:10.3949/ccjm.88a.20098

Gonzales D, Rennard SI, Nides M, et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. JAMA. 2006;296(1):47-55.

Mishra A, Chaturvedi P, Datta S, et al. Harmful effects of nicotine. Indian J Med Paediatr Oncol. 2015;36(1):24-31.

Kaufert JM, Rabkin SW, Syrotuik J, et al. A randomized trial comparing smoking cessation programs utilizing behaviour modification, health education or hypnosis. Can J Public Health. 1982;73(5):299-303.

Lynn SJ, Kirsch I, Hallquist MN. Social cognitive theories of hypnosis. In: Nash MR, Barnier AJ, eds. The Oxford Handbook of Hypnosis. Oxford University Press; 2008:111-139.

U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(8):622-634.